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ABSTRACT

PSYCHOMETRIC SYNTHESIS OF THE DRUG ABUSE SCREENING TEST 20ITEM VERSION (DAST-20)

By
Erin K. Johnson
August 2021

Dissertation supervised by Dr. David Delmonico
Numerous research articles have reported differing data on the psychometric
properties of the 20-item version of the Drug Abuse Screening Test (DAST-20, Skinner,
1982a). Aggregating this diverse information can lead to a better understanding of how to
use and interpret the instrument with clients and research participants. In this
psychometric synthesis, evidence of reliability and validity of the DAST-20 scores was
aggregated in order to provide a more comprehensive summary of the psychometric
properties of the instrument to better inform counseling professionals when using the
DAST-20. Overall, the available evidence indicates that the DAST-20 produces reliable
and valid scores when screening for drug abuse consequences. However, data was limited
and future research is needed to further assess the psychometric properties of the
instrument, including internal consistency, test-retest reliability, convergent validity,
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diagnostic validity, and structural validity. Implications for professional counselors and
counselor research are discussed.
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CHAPTER I: INTRODUCTION
Overview
According to the National Institute on Drug Abuse (NIDA, 2021b), a rise in the
use of illicit drugs has been observed in the United States. Based on data collected in
2018, the NIDA reported that 11.7% of Americans over the age of 12 years engaged in
illicit drug use within the previous 30 days. In the past two decades, an opioid crisis has
been reported, with a significant rise in the number of deaths related to opioid overdose
(U.S. Department of Health and Human Services [HHS], 2018). In 2017, there were
70,237 fatal drug overdoses in the United States (Scholl et al., 2019). Opioids contributed
to 47,600 of those deaths. Further, the HHS reported heroin overdoses rose by 400
percent in the previous ten years and synthetic opioid overdose contributed to a 300
percent increase in deaths in the previous seven years. In a study examining the
prevalence of fatal drug overdoses over a two-year period (2017-2018), a decrease in
overall fatal opioid overdoses was reported across the United States, which coincides
with a decrease in the prescription of opioids (Wilson et al., 2020). Although there were
fewer overall fatal opioid overdoses, synthetic opioid-related deaths increased by almost
10 percent over that two-year span.
Costs associated with drug use are assessed in three categories: crime, health care,
and productivity (NDIC, 2011). Illicit drug use costs more than 600 billion dollars
annually in the United States (NIDA, 2021a), which included a projected 120 billion
dollars in lost economic productivity. In 2013, prescription opioid abuse alone cost the
United States a projected $78.5 billion, including a projected 26 billion dollars in health
care.
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Given the prevalence of drug abuse, it is increasingly important to determine
effective screening practices, treatment procedures, and best practices among various
populations to identify drug abuse related consequences (Kiluk et al., 2018; USDHHS,
2018). Screening instruments are among the first steps in assessing for drug abuse and are
vital tools used by professionals to determine whether individuals abuse drugs
(Rasmussen, 2000). Since screening instruments are relied upon by evaluators to help
determine if problems related to an individual’s drug use are present, it is essential the
instruments yield valid and reliable scores. NIDA (2021b) indicated that out of the 22.7
million individuals in the United States who required treatment for drug abuse in 2013,
only 2.5 million received any specialized treatment. While many factors contributed to a
lack of treatment, use of robust screening instruments could be an important initial step in
identifying individuals for treatment. In addition to identifying individuals in need of
treatment, screening instruments are crucial in gathering information and identifying
problems related to drug use to ensure the most effective treatment is provided
(Rasmussen, 2000; Skinner, 1982a). One such screening instrument that identifies
problems related to drug abuse is the Drug Abuse Screening Test (DAST; Skinner,
1982b).
The DAST (Skinner, 1982b) was developed to screen for the presence of
consequences associated with drug abuse; currently there are four forms of the DAST
with varying numbers of items (i.e., DAST-28, DAST-20, DAST-10, DAST-A). The
DAST items ask about an individual’s drug use and any psychosocial problems that
resulted from drug abuse. Common psychosocial issues resulting from drug abuse include
psychological well-being, relationship strains, professional consequences, financial
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hardships, and legal trouble (Maly, 1993). Identifying the presence of these issues and
examining the extent to which they affect an individual’s life is essential in the
identification and treatment of drug abuse problems (Maly, 1993; Rasmussen, 2000). The
data gathered about the number and severity of problems stemming from an individual’s
drug abuse can assist clinicians and researchers in developing tailored treatment plans, as
well as in assessing how these issues will potentially affect an individual’s recovery
process (Rasmussen). Information should be gathered to help determine whether the
psychosocial issue being assessed was present prior to an individual’s problem drug use
and how the issue may impact use of drugs (Kiluk et al., 2018; Macleod, 2010;
Rasmussen).
The DAST was created in response to limited instruments available to screen for
consequences of drug use and abuse (Skinner, 1982b). Much like the Michigan
Alcoholism Screening Test (MAST; Selzer, 1968, 1971), upon which the DAST was
based, the DAST was established due to a lack of psychometrically sound instruments to
screen for addictions, as many of the resources available in the early 1980’s were
nonstandardized surveys with little psychometric support.
Statement of the Problem
This study examined psychometric data published by numerous researchers on the
DAST 20-item version (DAST-20; Skinner, 1982a). The various populations and settings
used in these studies have contributed to varying reports of psychometric values of the
DAST-20 items. These differences in findings can lead to a misunderstanding of how to
interpret results of this instrument, which can impact the effectiveness of the DAST-20 in
clinical and research settings (Erford, 2021). Even with similar samples, factors such as
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researcher, settings, and procedures can lead to varying results. This can be confusing for
clinicians and researchers looking at multiple studies with samples that closely match
their client. Lipsey and Wilson (2001) described aggregating the data from multiple
similar studies as “smoothing the resulting picture into a composite, much as a magazine
picture looks more crisp and coherent at arms length than when the pixels are examined
through a magnifying glass” (p. 167). By combining the results from all the relevant
studies, it provides a more robust examination of the results and allows for clinicians and
researchers to have a clearer picture of the data.
Researchers and clinicians have the responsibility to provide services that are
supported by empirical evidence and ethical guidelines (American Counseling
Association [ACA], 2014). Numerous ethical concerns need to be considered by
researchers and practitioners when choosing and using screening instruments with
individuals. ACA outlined ethical guidelines pertaining to the psychometric properties of
an instrument, the population for which the instrument is being used, and necessity of
providing empirical data that support the use of an instrument. The specific relevant
clauses follow along with commentary.
E.6. Instrument Selection E.6.a. Appropriateness of Instruments
Counselors carefully consider the validity, reliability, psychometric limitations,
and appropriateness of instruments when selecting assessments and, when
possible, use multiple forms of assessment, data, and/or instruments in forming
conclusions, diagnoses, or recommendations (ACA, 2014, p. 11).
Clause E.6.a (ACA, 2014) specifically considers the importance of examining the
psychometric properties of an instrument before using it with clients. Empirical data on
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an instrument should also be examined to assess the appropriate use with various
populations and settings and their implications for interpreting results. This can be
difficult when multiple sources are reporting differing reliability and validity values for
scores from a particular instrument (Erford et al., 2015). Since differences in study
conditions and samples can lead to differing outcomes, a psychometric synthesis can
provide an overall summary of the psychometric properties on an instrument, allowing
professionals in the field to have a better understanding of appropriate use of the
instrument (Cook et al., 1997; Erford et al., 2015; Lipsey & Wilson, 2001).
E.8. Multicultural Issues/ Diversity in Assessment
Counselors select and use with caution assessment techniques normed on
populations other than that of the client. Counselors recognize the effects of age,
color, culture, disability, ethnic group, gender, race, language preference,
religion, spirituality, sexual orientation, and socioeconomic status on test
administration and interpretation, and they place test results in proper
perspective with other relevant factors (ACA, 2014, p. 11).
Code E.8 (ACA, 2014) emphasizes the importance of considering many
multicultural facets when using a particular instrument and interpreting results. Varying
study samples can influence findings on psychometric properties of an instrument and
can make it difficult for professionals to know how to apply a client’s results (Cook et al.,
1997; Erford et al., 2015; Lipsey & Wilson, 2001).
E.9.b. Instruments With Insufficient Empirical Data
Counselors exercise caution when interpreting the results of instruments not
having sufficient empirical data to support respondent results. The specific
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purposes for the use of such instruments are stated explicitly to the examinee.
Counselors qualify any conclusions, diagnoses, or recommendations made that
are based on assessments or instruments with questionable validity or reliability
(ACA, 2014, p. 12).
A psychometric synthesis of the reported data can help summarize differences
among research findings due to sampling differences, allowing professionals to be more
accurate in determining when to use an instrument and how to interpret results (Cook et
al., 1997; Erford et al., 2015; Lipsey & Wilson, 2001).
This study will use psychometric synthesis procedures to extract all relevant data
and analyze the aggregated data from all included studies to provide a more
comprehensive interpretation of the psychometric properties of the DAST-20 (Erford et
al., 2015). This process allows a more inclusive and robust examination of the data to
inform clinicians and researchers using the DAST-20.
Purpose of the Study
Due to the prevalence of drug abuse and the importance of using screening
instruments that yield valid and reliable scores to assess individuals’ drug abuse and to
identify the need for treatment, further examination of instruments is essential. The
purpose of this study is to provide a comprehensive analysis of the psychometric
properties of DAST-20 by conducting a psychometric synthesis using the findings from
the identified relevant studies. The results will provide insight into the validity and
reliability of the DAST-20 scores and inform clinicians and researchers who use it for
screening and research purposes by providing a more comprehensive summary of DAST-
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20 psychometric properties (e.g., internal consistency, test-retest reliability, convergent
validity, structural validity, diagnostic validity).
A psychometric synthesis shares many characteristics with a meta-analysis,
however, a meta-analysis is a specific order of procedures and statistical methods that are
used to examine the outcome of a treatment program or intervention, whereas a
psychometric synthesis is used to examine the psychometric properties (e.g., reliability
estimates, validity estimates, descriptive statistics) of an instrument (B. T. Erford,
personal communication, June 25, 2021). Both provide an empirical process to examine
the data from various studies on a shared topic of interest to produce an aggregated
analysis of outcomes (Erford et al., 2015). As such, the results can provide a more
comprehensive summary of the data than looking at each of the studies individually
across various populations and study characteristics to allow professionals to make more
informed decisions about using and interpreting the DAST-20. By examining the analysis
of the aggregated data, researchers can identify limitations of particular studies and
differences in conditions that may lead to varying outcomes (Cook et al., 1997; Lipsey &
Wilson, 2001). Therefore, psychometric synthesis studies can provide clarity on why
these differences might occur and what their implications might mean in counseling
practice, which allow for a more unbiased view of outcomes and a more in-depth
examination of various conditions that affect results. Further, the procedure of examining
the aggregated data from the included studies results in a reduction in sampling error,
which allows a more robust report of findings (Lipsey & Wilson, 2001). In this
dissertation, an aggregated analysis of the psychometric properties of the DAST-20 will
be reported and implications discussed.
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There are currently four versions of the Drug Abuse Screening Test occurring in
the literature, including the original DAST (28 items), the DAST-20 (20 items), the
DAST-10 (10 items), and the DAST-A (a version created for use with adolescents). The
20-item and the 10-item versions of the DAST were created after conducting an itemanalysis of the original 28-item DAST (Skinner, 1982b, 1984). A very high correlation
was found between the DAST-20 and the original 28-item version of the DAST (r = .99)
(Skinner, 1982b). This study specifically examined the psychometric properties of the
DAST-20.
In the current study, examination of the DAST and DAST-A versions of the
instrument were eliminated because the abbreviated versions were highly correlated with
the original 28-item version and the DAST-A was specific to only the adolescent
population. Examination of the DAST-20 was chosen over the DAST-10 based on
Skinner’s (1984) recommendations for the use of each version. The DAST-20 produces a
more comprehensive evaluation of the individual’s consequences that result from drug
abuse and has been recommended for use at “specialized assessment centres and for use
as a research evaluation tool,” whereas the DAST-10 has been recommended for
“screening and case finding purposes” (Skinner, 1984, p. 30). Therefore, the findings of
this study may be more useful to individuals using the DAST in both clinical and
research settings. Further studies should be completed on the other forms of the DAST
instrument in the future.
Research Questions
Three research questions form the basis of this study:
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1. What are the aggregated psychometric properties of the DAST-20 across published
studies (i.e., internal consistency, test-retest reliability, diagnostic validity, internal
structural validity, external convergent validity)?
2. What are the mean scores and standard deviations of the DAST-20 in nonclinical
samples across published studies?
3. Are there significant differences in the psychometric properties of the DAST-20
among various sample characteristics (e.g., gender)?
Theoretical Orientation to the Study
As previously stated, the DAST (Skinner, 1982b) measures the presence of
consequences related to an individual’s drug use. Impaired functioning theory posits that
drug abuse has a negative impact on an individual’s functioning, which leads to issues in
various aspects of life (Newcomb & Bentler, 1988). Further, impaired functioning theory
provides a framework for categorizing consequences of drug abuse into physical,
emotional, and psychological domains. Impairment in any of these domains can lead to
problems coping with life’s stressors and completing a number of daily tasks. This theory
supports the use of the DAST to measure consequences related to an individual’s drug
use and the items that are included on the DAST. The 20 items on the DAST-20 inquire
about one’s drug use and related consequences concerning physical health, relationships,
and functioning at work (Skinner, 1982b). Impaired functioning theory will be discussed
in further detail in Chapter 2.
Significance of the Study
This study provides an integrated analysis of the psychometric properties of the
20-item version of the DAST, including internal consistency and test-retest reliability,
9

diagnostic validity, internal structural validity, external convergent validity, and
nonclinical sample means and standard deviations. The analysis of these psychometric
properties will provide professionals with a more comprehensive understanding of the
instrument, which can be used to guide their work with clients (Erford et al., 2015). More
specifically, professionals will have better insight when using this instrument with their
clients, of implications when interpreting results, and applying this information to create
treatment plans with clients. At a broader level, integrative syntheses can have an impact
on policy and best practices due to a more robust examination of results (Lipsey &
Wilson, 2001).
Summary of Methodology
In the current study, a psychometric synthesis process will be conducted to
examine psychometric findings on the 20-item version of the Drug Abuse Screening Test
(DAST-20; Skinner, 1982a) since 1982. A psychometric synthesis was chosen as the
methodology for this study because it allows for the examination of all available data on
the psychometric properties of an instrument, creating an aggregated summary of the
reliability and validity (Erford et al., 2015). The process of a psychometric synthesis
involves collecting all possible data from studies examining a common research question
that meet the established criteria included in the study and using particular statistical
procedures to aggregate and summarize these findings. The procedure used in this study
was outlined by Erford et al. (2015) in a synthesis that examined the psychometric
properties of the Beck Depression Inventory – Second Edition (BDI-II). This procedure
includes establishing criteria for article inclusion, searching for relevant articles,
examining articles for criteria and completing the selection process, data extraction, and
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data analysis. A more comprehensive examination of the psychometric synthesis process
and the methodology used in this study will be provided in Chapter 3.
Delimitations of the Study
One criterion required for prospective studies to be accepted in the psychometric
synthesis was the linguistic version of the DAST-20 used in the study and the language in
which the study was published. This criterion helped to eliminate issues with translation
and adaptation, but it is also important to note that there are other studies published with
different linguistic versions of the DAST-20 and potentially relevant studies published in
other languages that could not be included in the analysis (Lipsey & Wilson, 2001).
Further studies are needed to examine these potential studies and the instruments’
psychometric properties across cultures.
This study also only examines the DAST-20. Other versions of the DAST (i.e.,
DAST, DAST-10, DAST-A) were not included in the study. Therefore, the results of this
study can only be applied to guide one’s use of the English version of the DAST-20.
Similar synthesis studies are needed to examine the psychometric properties of the other
versions of the instrument.
Further, the data used in this psychometric synthesis are limited by how detailed
the researchers of the included studies were in reporting their findings. The extraction of
data was completed by reviewing the full text version of each study and, therefore, only
the data that was provided in the articles could be used in this analysis of the
psychometric properties of the DAST-20.
It is important to note the general limitations of psychometric syntheses and the
criticisms that have been made about the process and reporting of results (Erford et al.,
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2015; Lipsey & Wilson, 2001), which have certain potential limitations, regardless of the
topic being studied. For example, the specific factors of the studies, such as methodology,
population, and analysis of data may have implications for the scope of the analysis.
Significant factors, such as study limitations, cultural implications, theoretical
framework, and the power and quality of the study may be overlooked in the overall
analysis.
Key Terms
Drug abuse – Many terms were used in the literature to refer to drug abuse (i.e., drug use,
drug use disorder, substance abuse, substance use, etc.). For the purposes of this study,
the term “drug abuse” will be used to refer to Skinner’s (1982a) definition of drug abuse
as used in the DAST and its various forms: “…‘drug abuse’ refers to (1) the use of
prescribed or over the counter drugs in excess of the directions and (2) any nonmedical
use of drugs” (p. 4).
Clinical sample – A sample that was selected using a specific diagnosis (e.g., substance
use disorder) as a criterion to be included in the study.
Nonclinical sample – A community sample in which no criterion was used for participant
inclusion in the study.
Summary of Chapter 1
Due to an increase in illicit drug use and the disparity between the proportions of
individuals requiring treatment for drug abuse and those individuals who actually receive
treatment (NIDA, 2018), it is essential for medical and mental health professionals to use
psychometrically sound instruments to screen for drug abuse and related consequences
and the information needed to accurately interpret results. The purpose of this study is to
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analyze the psychometric properties of the DAST-20 and provide an overall summary of
the instrument in order to give clinicians and researchers a more comprehensive
understanding of the usefulness of the instrument. The implications of using the DAST20 with particular populations and for interpretation of results will be discussed. In this
chapter, the study was introduced, and the problem, purpose, and significance of the
current study discussed. In Chapter 2, the current literature on drug abuse and the DAST20 will be reviewed.
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CHAPTER 2: REVIEW OF THE LITERATURE
Due to the prevalence and severity of drug abuse, it is imperative that professional
services are available to aid individuals dealing with substance abuse problems. In order
to provide the most effective treatment, professionals in the field need to have screening
and diagnostic tools available that yield reliable and valid scores to correctly identify
individuals with drug abuse. This study aims to examine one of these instruments, the 20item version of the Drug Abuse Screening Test (DAST-20), which examines the presence
of consequences related to drug abuse. An overall analysis of the psychometric properties
of the instrument will be conducted. In this chapter, relevant literature on substance
abuse, consequences related to substance abuse, issues pertaining to causality, ethical
considerations, theoretical orientation, and a background on the formation and initial
examination of the psychometric properties of the DAST-20 will be reviewed.
Substance Abuse
Rasmussen (2000, p. 8) defined substance abuse as “a maladaptive pattern of
substance use that leads to clinically significant impairment or distress.” The use of
substances can lead to various consequences that affect an individual’s social, physical,
psychological, occupational, and legal domains (APA, 2013; Newcomb & Locke, 2005;
Rasmussen, 2000). The American Psychiatric Association (APA, 2013) provided
diagnostic guidelines for assessing substance use disorders. Although there are slight
variances among classes of substances and diagnostic criteria, the main tenet that defines
all diagnoses of a substance use disorder is the ongoing use of a substance, regardless of
the presence of symptoms, and problems that occur associated with the individual’s use
of the substance. According to the Diagnostic and Statistical Manual of Mental
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Disorders, 5th edition (DSM-5; APA, 2013), there are 11 criteria used to diagnose
substance use disorder, regardless of the illicit substance being used. These 11 criteria are
organized in four categories: impaired control, social impairment, risky use, and
pharmacological.
The first category, impaired control, includes criteria one through four, which
dictate that an individual may increase dosage or use the substance for an extended
amount of time, display an inability to reduce dosage or frequency of use, devote a
significant portion of their time to either procuring, using, or recuperating from the
substance, and exhibit cravings for the substance. The second category, social
impairment, consists of criteria five through seven, which indicate that the individual is
experiencing decreased functioning in required tasks at work, school, or home, relational
issues, and a decrease in participation of social activities.
Risky use is categorized by criteria eight and nine, which assess an individual’s
substance use regardless of potential physical harm. Criterion eight indicates that an
individual is repeatedly using substances in dangerous settings, whereas criterion nine
indicates continual use of the substance regardless of physical or psychological
consequences. Lastly, the pharmacological category includes criteria 10 and 11, which
signify problems of tolerance and withdrawal to the substance.
Substance use disorder exists along a continuum ranging from mild to severe.
These disorder levels are determined by the number of criteria evident in relation to an
individual’s substance use. The DSM-5 standards for determining which severity
category (mild, moderate, or severe) an individual’s substance use disorder falls under is
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defined as two to three criteria present, four to five criteria present, and six or more
criteria present, respectively (APA, 2013).
Consequences Related to Drug Use
The DAST-20 is focused specifically on measuring the presence of consequences
as an outcome of drug abuse. This is one method for determining the degree of severity
the drug addiction has on an individual’s life. Research has provided evidence of
significant relationships between drug abuse and the consequences an individual
experiences. Consequences related to drug abuse can occur in various areas of an
individual’s life, including physical health, psychological, and social issues, all of which
can be classified as short-term or long-term effects (Newcomb & Locke, 2005). A more
thorough understanding of the potential consequences of an individual’s drug abuse can
allow professionals to provide a more effective treatment plan when working with a
client (Skinner, 1982a).
Physical Health-related Consequences
Drug abuse was linked to various physical health issues, which ranged in severity
depending on the drug being abused and the frequency and quantity of use (Newcomb,
1997; Rasmussen, 2000). Rasmussen categorized physical health problems resulting from
drug abuse as gastrointestinal issues, dermatological side effects, genitourinary signs,
neuromuscular issues, cardiovascular issues, respiratory issues, and physical trauma
related to one’s drug use. Gastrointestinal issues can range from mild side effects of a
particular drug (e.g., nausea, constipation, diarrhea) to developing more serious
complications such as hepatitis and cirrhosis (Lange et al., 1992; Rasmussen, 2000).
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Depending on the drugs used and the method of ingesting drugs, individuals may
experience dermatological issues such as increased perspiration, complexion fluctuations,
scarring due to burns or needle marks, as well as rashes, bruises, and skin infections
(Rasmussen, 2000). Individuals who abuse drugs are also at a higher risk of developing
sexually transmitted diseases. Infections and a weakened immune system were also
associated with drug abuse (Lange et al., 1992). Neuromuscular issues were associated
with drug abuse and included problems such as “slurred speech, tremors, lack of
coordination, poor muscle tone, extremity weakness, hyperactive reflexes, seizures, and
coma” (Rasmussen, 2000, p. 3). Further, individuals who abuse drugs can experience side
effects such as “chest pain, palpitations, and various cardiac dysrhythmias” and blood
pressure, heart rate, and breathing fluctuations (Rasmussen, 2000, p. 4). It is not
uncommon for physical trauma to occur as a result of accidents and/or altercations related
to one’s drug abuse (Lange et al., 1992; Rasmussen, 2000).
The DAST-20 (Skinner, 1982a) has two items that ask about physical symptoms
and consequences that resulted from an individual’s drug abuse. Item 17 asks “Have you
ever experienced withdrawal symptoms (felt sick) when you stopped taking drugs?” and
item 18 asks individuals “Have you had medical problems as a result of your drug use
(e.g., memory loss, hepatitis, convulsions, bleeding, etc.)?”
Psychological Consequences
Several studies indicated a significant relationship between drug use and
psychological issues (Gove et al., 1979; Newcomb & Locke, 2005; Newcomb et al.,
1999). In a study examining individuals’ drug use and psychological well-being, a
significant positive correlation was found between the number of types of drugs an
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individual used and their overall psychological well-being and symptoms of mental
health issues (Gove et. al, 1979). These researchers cautioned about the inability to
determine directionality of this correlation, however, and posited a theory that an
individual’s psychological issues contributed to the decision to use drugs as an attempt to
increase overall psychological well-being.
Newcomb et al. (1999) found evidence of a reciprocal relationship between drug
abuse and psychological well-being when conducting a four-year longitudinal study of a
community sample of 470 adults, measuring participants’ overall psychological wellbeing and drug use status. These researchers found significant positive correlations
between drug abuse and “dysphoria, agitation, psychoticism, and disorganized thinking”
(p. 421). However, there was evidence of both drug abuse following psychological
problems, as well as preceding psychological problems. Dysphoria reported at the initial
survey was correlated with an increase in alcohol consumption four years later. Thoughts
of suicide and lower self-esteem present initially was positively correlated with drug use
four years later. Further, drug abuse at the initial survey was correlated with increased
anxiety and hostility and decreased feelings of purpose four years later. Marijuana use at
the initial survey was associated with an increase in suicidal ideation and psychoticism
four years later and cocaine use initially was associated with an increase in hostility.
Social Consequences
Interpersonal issues were associated with drug abuse, including relationship
strains with family members and friends (Rasmussen, 2000). It is not uncommon for drug
abuse to cause issues within a family, including parenting issues (Newcomb & Locke,
2005; Rasmussen, 2000; Visser, 1991), separation or divorce (Rasmussen, 2000; Visser,

18

1991), as well as physical and emotional neglect of family members (Visser, 1991).
Visser stated that a parent with drug abuse problems can have difficulty providing what a
child needs physically and emotionally, which can lead to neglect and abuse. In a study
examining the correlation between parental drug abuse and the occurrence of child abuse,
researchers found the rate of child abuse more than doubled among families where at
least one parent had a drug abuse problem (Walsh et al., 2003). Substance abuse also was
associated with a decrease in the overall functioning and satisfaction of a
marriage/relationship (Newcomb, 1997). Friendships can also deteriorate (Rasmussen,
2000). The impact of substance abuse on relationships can result in a loss of a social
support network. According to Visser (1991), consequences of drug abuse within a
family, including dysfunction among family members and feelings of guilt and shame
about the drug abuse, can lead to isolation from not only those close to the family, but
from society in general.
The DAST-20 (Skinner, 1982a) includes items that inquire about the social
consequences of drug abuse. Items 8-11 address the effects of drug use on relationships
with family and friends. Item 8 states, “does your spouse (or parents) ever complain
about your involvement with drugs?;” item 9 asks “has your drug abuse created problems
between you and your spouse or your parents?;” and item 11 asks “have you neglected
your family because of your use of drugs?”
Drug abuse can also have a negative impact on an individual’s career (Newcomb,
1997; Newcomb & Locke, 2005; Rasmussen, 2000). Researchers found that drug abuse is
associated with impaired functioning at work, an inability to focus on tasks, a rise in
absenteeism, an increase in errors, lapses in judgement, unnecessary risk-taking, and
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negligent actions (Rasmussen, 2000). Due to these issues, it is not uncommon for
individuals to experience job loss or repeated changes in employment (Galaif et al., 2001;
Rasmussen, 2000). In a study examining the relationship between drug abuse and job
adjustment among a community sample of adults, Galaif et al. found a significant
correlation between occupational consequences and drug abuse. More specifically,
individuals who reported issues with drug abuse had an increased chance of experiencing
issues such as unpredictable employment and lowered overall work satisfaction.
There are two items on the DAST-20 that inquire about job/work consequences
resulting from drug abuse. Item 12 states, “have you been in trouble at work (or school)
because of drug abuse?” and item 13 asks “have you lost your job because of drug
abuse?” (Skinner, 1982a).
Legal issues are another commonly reported consequence of drug abuse. Thus,
legal issues were included in the DSM-5 as one criterion used to assess the presence of
drug abuse (APA, 2013; Newcomb & Locke, 2005; Rasmussen, 2000). At the end of
2016, approximately 15% of inmates in state-level correctional facilities were charged
with a drug-related crime (Bronson & Carson, 2019). Items 14 through 16 on the DAST20 assess the presence or absence of legal consequences experienced due to drug abuse:
“have you gotten into fights when under the influence of drugs?;” “have you engaged in
illegal activities in order to obtain drugs?;” and “have you been arrested for possession of
illegal drugs?;” respectively (Skinner, 1982a). The remaining seven items on the DAST20 ask the individual about drug use activity and frequency (items 1 through 5), as well
as drug treatment history (items 19 and 20; Skinner, 1982a).
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It is important to note that instruments which examine the presence and severity
of consequences due to drug abuse do not necessarily identify which consequences are a
direct result of the drug abuse (Kiluk et al., 2018; Macleod, 2010). In a study that
examined drug abuse and work adjustment, Galaif et al. (2001) found drug abuse not only
had a significant impact on overall work adjustment, but individuals who had
experienced unpredictable employment status earlier in life were more likely to report
drug abuse four years later. Macleod (2010) argued that when considering environmental
factors and adversity, professionals in the field need to
distinguish between (a) situations where drug use mediates the association
between disadvantage and psychosocial harm, (b) situations where drug use
causes harm irrespective of any association with disadvantage, and (c) situations
where drug use is mainly a marker of a toxic environment that causes harm
through other pathways.” (p. 25)
Similarly, when discussing the Addiction Severity Index (ASI), another
assessment that measures an individual’s addiction severity within different psychosocial
categories, Kiluk et al. (2018) indicated that although the severity of issues may be
measured, it does not necessarily indicate issues and severity due to one’s addiction. For
example, the issues present may be a result of substance abuse and present prior to
substance use. In this case, the problem contributed to one’s substance abuse, and the
substance abuse may or may not continue to impact problem severity. Newcomb (1997)
examined many facets of the consequences associated with drug abuse and argued that
while drug abuse likely led to the deterioration of relationship quality, poor relationship
quality may also impact drug abuse.
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Although consequences may be associated with the presence of drug use, it is
important not to assume that the relationship between the factors are causal or
unidirectional. Therefore, ethical obligations and best practices require further data
collection to examine the relationship between drug use and problems present. Skinner
(1982a) included the criterion of drug use in each item of the DAST-20 instrument. Each
item asks about the presence of a consequence in relation to an individual’s use of drugs.
For example, item 10 asks the individual to answer in yes or no format the question,
“Have you lost friends because of your use of drugs?” This criterion may aid in the
identification of issues that are a consequence of substance abuse based on the
individual’s perception of their issues.
Impaired Functioning Theory
Impaired functioning theory is based on the premise that drug abuse causes
physical, psychological, and emotional consequences in an individual’s life (Newcomb &
Bentler, 1988). The negative consequences “can result from the psychoactive effects of
the drug on cognitive, affective, and behavioral processes…[or]…arise from the
deleterious effects due to the mode of ingestion and/or the metabolizing of the substance
by the body on the physical level” (p. 26). The impaired functioning theory postulated
that the psychoactive effects on an individual’s various processes can lead to alteration of
one’s insight, awareness, ability to focus and process information, and/or emotional
expression. Due to the differences in functioning among the various domains, an
individual may have difficulty performing daily activities and coping with life’s stressors.
The tenets of the impaired functioning theory provide a supportive framework for the
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consequences of drug abuse across three domains of an individual’s life: physical health,
psychological well-being, and social impairment.
Assessment and Screening Instruments
Assessment is a critical process in clinical and research practices. Assessment is
necessary to ensure clients are accurately diagnosed and receive the care and resources
needed (Erford, 2021). Screening, typically one of the first steps in assessment, is used
with the goal of identifying the need for further assessment. Screening instruments are
not intended for diagnostic purposes, but instead identify the potential need for a more
comprehensive, diagnostic assessment (Erford, 2021; U.S. Preventative Services Task
Force [USPSTF], 2020). Although screening instruments are not robust enough to be
considered appropriate for diagnostic purposes, it is important that they yield valid and
reliable scores to ensure that the proper decision is being made as to whether or not an
individual is referred for further assessment. Screening instruments that yield valid and
reliable scores help ensure that false negative results do not occur, reducing the risk that
an individual who should be referred for further diagnostic assessment does not get
overlooked (Erford, 2021).
Screening instruments that assess drug abuse are classified as either logically
derived instruments or empirically derived instruments (Piazza et al., 2000). Logically
derived instruments are direct in what is being measured and tend to demonstrate high
content validity, but are at higher risk for response bias and, therefore, false negatives.
Empirically derived instruments that assess drug abuse include items that are not
necessarily directly asking about drug abuse, however, have high predictive validity of
the presence of drug abuse. This type of drug abuse screening instrument may produce
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less risk of response bias; however, it is limited in what information can be gleaned about
an individual’s drug abuse.
Multiple screening instruments exist to assess individuals for the potential
presence of drug abuse, related consequences, or severity of use (USPSTF, 2020). Given
the availability of screening instruments assessing drug abuse, clinicians and researchers
have multiple considerations when choosing to use a specific assessment, such as client
age, length of the assessment, assessment delivery format, pertinent characteristics of a
client, and associated financial costs (NIDA, 2018; USPSTF, 2020).
Drug Abuse Screening Test (DAST)
The Drug Abuse Screening Test (DAST; Skinner, 1982a) is a 28-item self-report
instrument developed to determine the severity of the impact of drug abuse on an
individual’s life. The DAST is a logically derived instrument intended to provide a means
for screening for drug abuse as well as researching and evaluating treatment. Skinner
indicated that the DAST can be used in conjunction with other data collection methods to
gain more insight into an individual’s issues related to their drug abuse and to measure
the effects of treatment.
The DAST is given by means of self-administration or interview (Skinner, 1982a,
1984). Self-administration allows delivery to multiple individuals in an efficient manner.
Skinner (1982a) suggested the self-administration method may help lessen bias and
under-reporting of issues to allow more valid responses. However, an interview format is
recommended for individuals who may have difficulty comprehending the material.
The 28 items require the responder to answer in a yes or no format for each
question (Skinner, 1982a). The individual taking the assessment is instructed to answer
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the questions based on drug use over the course of the past 12 months with the exception
of alcohol use. Skinner (1982a) defined drug abuse in the questionnaire instructions as
(1) the use of prescribed or over the counter drugs in excess of the directions and
(2) any non-medical use of drugs. The various classes of drugs may include:
cannabis (e.g. marijuana, hash), solvents, tranquillizers (e.g. Valium),
barbiturates, cocaine, stimulants (e.g. speed), hallucinogens (e.g. LSD) or
narcotics (e.g. heroin) (p. 1).
Since the development of the initial 28-item version of the DAST, three additional
formats have been developed, including DAST-20, DAST-10, and DAST-A. The DAST20 and the DAST-10 are both shorter versions of the DAST comprised of 20 and 10
items, respectively. The DAST-A was created for use with adolescents.
DAST-20
The DAST-20 version contains 20 yes or no questions about an individual’s drug
abuse and the number of consequences associated with drug abuse (Skinner, 1982a). The
questions assess presence of consequences in various aspects of an individual’s life,
including issues with friends, family, work, incarceration, and physical and medical
implications. The DAST-20 is recommended for use in clinical settings and for research
evaluation as it provides more information about an individual’s consequences related to
drug abuse than the DAST-10 (Skinner, 1984).
The DAST-20 is scored by applying values of either 1 or 0 based on whether the
individual responded with yes or no for a particular question (Skinner, 1982a). For all but
two questions, a response of “yes” results in a score of 1, indicating an issue associated
with substance abuse is present and a response of “no” results in a score of 0. Items 4
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(“Can you get through the week without using drugs?”) and 5 (“Are you always able to
stop using drugs when you want to?”) have reverse scoring procedures, as a “yes”
response indicates less negative impact of drug abuse. The score can range from 0 to 20,
which represents a range of severity of consequences associated with an individual’s
substance abuse; a lower score indicates less severity of consequences associated with
substance abuse with a score of 0 signifying that there were no consequences associated
with substance abuse reported by an individual.
Additional Forms of the DAST
The DAST was also reduced to 10 yes or no items (DAST-10). Skinner (1984)
recommended the DAST-10 be used to screen for drug abuse consequences since it does
not provide as much information about an individual’s consequences. Still, scores on the
DAST-10 were found to have psychometrically sound characteristics.
The DAST-A is an adolescent version that includes items similar to the DAST-20,
but the 20 questions focus on relationships with parents when assessing relationship
consequences and on school when assessing an adolescent’s ability to function. In
contrast, the DAST-20 includes relationships with spouses/partners and occupational
consequences (Skinner, 1982b). The instrument is scored in the same manner as the
DAST-20. Values of either 0 or 1 are added together based on whether the individual
responded with “yes” or “no” for a particular question. For all but two questions, a
response of “yes” results in a score of 1, indicating a consequence associated with
substance abuse is present and a response of “no” results in a score of 0. As with the
DAST-20, items 4 (“Can you get through the week without using drugs?”) and 5 (“Are
you always able to stop using drugs when you want to?”) have reverse scoring
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procedures, as a “yes” response indicates less negative impact of drug abuse. The score
can range from 0 to 20, which represents a range of severity of consequences associated
with an individual’s substance abuse; a lower score indicates less severity of
consequences associated with substance abuse with a score of 0 signifying that there were
no consequences associated with substance abuse reported by an individual.
The DAST-20 was chosen for the current study due to the various uses and
settings recommended by Skinner (1982a) when compared to the DAST-10 and for the
broader demographics with which it is commonly used, compared to the adolescent
version of the instrument.
DAST Formation
The DAST (Skinner, 1982b) was developed based on the Michigan Alcoholism
Screening Test (MAST; Selzer, 1971). The MAST was developed to address the absence
of a standardized instrument to identify the presence of alcoholism. Selzer found that the
instruments available were based on varying definitions of alcoholism and alcohol abuse
and relied on poorly defined categorizations of individuals’ alcohol consumption as
opposed to the consequences an individual is experiencing due to their alcohol use. For
example, some definitions of alcoholism included invalid observations of one’s
appearance and hygiene (Selzer, 1968). Discordant and invalid definitions of alcoholism
made it difficult to identify individuals with an actual alcohol use problem. A
standardized instrument that could produce valid and reliable scores was needed to help
identify individuals with alcoholism (Selzer, 1968, 1971).
The MAST (Selzer, 1971) is comprised of 25 yes or no questions that inquire
about an individual’s consequences associated with use of alcohol related to relationships
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with family and friends, work issues, health problems, legal issues, and psychological
consequences. Scoring of the MAST is based on the magnitude of each item in
addressing alcoholism (Selzer, 1968). A cumulative value of four or more points is
considered a positive screening for alcoholism. Studies have indicated that the MAST is a
psychometrically sound instrument for screening purposes (Skinner, 1984). A synthesis
of the psychometric properties of the MAST scores revealed an aggregated internal
consistency coefficient of .84, indicating the MAST to yield reliable scores for screening
for alcohol-related issues; however, this value fell short of the recommended coefficient
of .90 for diagnostic purposes (Minnich et al., 2018).
Consequences related to alcohol abuse can be compared to consequences an
individual can experience from drug abuse (Skinner, 1984). Therefore, Skinner (1982b)
created the DAST based on the MAST to provide an instrument that could screen for
drug abuse consequences.
Initial Evaluation of the DAST-20
The initial evaluation of the score validity and reliability of the DAST yielded
positive results for all forms of the instrument (Skinner, 1982b). Skinner examined the
psychometric properties of the original 28-item version of the DAST in a study that
sampled 223 individuals in an addiction treatment program and DAST scores had high
internal consistency (KR-20 = .92).
Scores from the DAST-20 were highly correlated with the 28-item DAST (r =
.99) and DAST-10 (r = .98) among the total sample (Skinner, 1984). The DAST-28 and
DAST-10 scores correlated r = .97. High internal consistency was reported for the
DAST-20 scores (KR-20 = .95) for the entire sample (including substance abuse of drugs
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and/or alcohol) and for a subgroup that did not include participants who reported only
abuse of alcohol (i.e., drug use only; KR-20 = .86; Skinner, 1982b).
An evaluation of the DAST-A was conducted by Martino et al. (2000) with
adolescents in an inpatient facility. The DAST-A scores were significantly positively
correlated with five related instruments. The researchers also found that the DAST-A
scores had adequate internal consistency (KR-20 = .91) and test-retest reliability (r = .89).
Advantages and Limitations of the DAST
Skinner (1982a) identified numerous advantages and limitations of using the
DAST to assess an individuals’ level of issues associated with substance abuse. The
DAST is a cost-efficient (i.e., free) means of collecting a measure of drug abuse impact
that can be administered individually or in a group format (Skinner, 1982a, 1984). The
DAST not only provides an overall score indicating the level of consequences associated
with drug abuse, but also can be used as a foundation to gain further data and information
on the identified areas most affected by drug abuse. The DAST can be used in
conjunction with other instruments to validate findings. However, the DAST is
susceptible to participants underreporting their substance abuse. Also, the DAST is not a
comprehensive assessment of all aspects of an individual’s substance abuse and should be
used in conjunction with other means of collecting data.
Psychometric Properties of the DAST-20 Scores
Since the initial study on the psychometric properties of the DAST-20 scores
(Skinner, 1982b), numerous studies reported quantitative data on the reliability and
validity of DAST-20 scores among various populations (Cassidy et al., 2008; Cocco &
Carey, 1998; Grekin et al., 2010; Salehi et al., 2012). Due to varying research conditions,
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limitations, and populations, differences in psychometric properties of the DAST-20 have
been reported, which can have a significant effect on a professional’s ability to interpret
and apply DAST-20 scores in treatment and research (Erford et al., 2010; Lipsey &
Wilson, 2001). A preliminary review of these findings is summarized below.
Reliability
Numerous studies reported internal consistency values for the DAST-20 scores
(Aubry et al., 2011; Bliss et al., 2008; Boyd et al., 2009; Brocato & Wagner, 2008;
Burnett et al., 2013; Cassidy et al., 2008; Fineran et al., 2010; Forbey & Ben-Porath,
2008; Forbey et al. 2011; Gerlock, 2004; Kaslow et al., 2006; Kimbrel et al., 2011;
Murphy et al., 2007; Nordfjaern, 2013; Perepletchikova et al., 2012; Reviere et al., 2007;
Rosenkranz et al., 2012; Sabato et al., 2013; Sullivan et al., 2009; Ting et al., 2009).
Among these studies, the reported reliability value (KR-20) ranged from 0.71
(Rosenkranz et al., 2012) to 0.998 (Cassidy et al., 2008). Erford (2021) recommended
internal consistency values of at least .80 to consider scores from an instrument
acceptable for screening purposes and at least .90 for use as a diagnostic tool. Such large
variances in reported internal consistency values can affect best practice across diverse
populations.
Validity
Data on the validity of the DAST-20 scores were reported in numerous studies
over the last few decades. Convergent validity was demonstrated with scores from the
DAST-20 and similar instruments, including the MMPI-2 Restructured Clinical Scales
(Forbey & Ben-Porath, 2008), the Externalizing Inventory (100-item; Hall et al., 2007),
the MAST (Marshall & Marshall, 2006), the Marijuana Screening Inventory (MSI-X;
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Alexander & Leung, 2006), the Research Institute on Addictions Self-Inventory (Shuggi
et al., 2006), the NEO-PI-R (Conner et al., 2004), the CAGE and the SASSI-2 (Teslak,
2000), and the ADS and MAST (Gavin et al., 1989). Further analysis and discussion of
findings in regard to convergent validity will be provided in the Results and Discussion
sections of this study.
Multiple studies reported data on the diagnostic validity (decision reliability) of
the DAST-20 scores with varying findings on the sensitivity, specificity, positive
predictive power, and negative predictive power. Multiple cut-off scores have been
recommended across these studies. The data reported from these studies on the criterion
validity of the DAST-20 will be summarized in the Results chapter of this study.
Ethical Considerations When Using Screening Instruments
Counselors and researchers must take numerous ethical considerations into
account when choosing instruments to use with clients and research participants.
Specifically, the American Counseling Association (ACA, 2014) outlined ethical
standards pertaining to the psychometric properties of an instrument, the population in
which instruments are used, and empirical data that support the use of an instrument.
These specific clauses include E.6.a, E.8, and E.9.b.
ACA’s Code of Ethics (2014) supports the need for various methods of data
collection when working with clients and research participants in order to gather a more
complex understanding of an individual’s drug use and psychosocial factors. When using
instruments, professionals also need to be aware of any multicultural considerations that
may affect score reliability and validity of an instrument and how results are interpreted.
For example, researchers reported differences between the consequences experienced by
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men and women due to substance abuse (Newcomb, 1997; Plant et al., 2002; Robbins,
1989). Robbins found women were more likely to report consequences of depression,
trust issues, and feeling distressed, whereas men were more likely to report issues related
to school, work, finances, legal problems, driving under the influence, and urgent health
issues. The reported differences between men and women were attributed to men’s higher
occurrence of substance abuse than women. Women who reported abusing marijuana and
cocaine were also more likely to report relational consequences such as engaging in
altercations and arguments. In contrast, a study conducted using a cross-sectional survey
of individuals in the United Kingdom found that women were more likely than men to
report negative consequences due to substance abuse (Plant et al.). Although various
studies reported on differences in experiences among men and women, these differences
are not always considered by clinicians and researchers (Newcomb).
Another example of multicultural factors that could have significant impact on
outcomes is age (Newcomb, 1997). Newcomb made the argument that different
consequences of drug abuse may be present depending on an individual’s age and the
tasks that occur during that particular life stage.
Issues with Application of Individual Study Results
It is not uncommon for researchers conducting similar studies to report
contradicting results leading to differing conclusions (Erford et al., 2015; Lipsey &
Wilson, 2001). This can make it difficult for professionals to know how to implement the
conclusions from the various studies when working with clients. The differences in
findings among the various studies can be attributed to the specific samples, researchers,
methods, and conditions of each individual study. Many of the samples in the studies that
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reported data on the psychometric properties of the DAST-20 are very specific and not as
generalizable to the population of clients of mental health professionals. Some examples
of these samples include patients with burn injuries (Salehi et al., 2012), individuals with
a mental disorder (Cocco & Carey, 1998), women who recently gave birth (Grekin et al.,
2010), and individuals with first-episode psychosis (Cassidy et al., 2008). Further, some
studies used clinical samples while others used nonclinical samples, and even different
diagnostic criteria (e.g., DSM, ICD, author created) were used to assess the psychometric
properties of the DAST-20. Multiple studies reported issues of generalizability of results
in the discussion of study limitations (e.g., Alexander & Leung, 2006; Grekin et al.,
2010).
Much like a meta-analysis, a psychometric synthesis can allow for a more
comprehensive examination of a topic, which better informs professionals making
decisions based on the available literature (Erford et al., 2015; Lipsey & Wilson, 2001).
Lipsey and Wilson explained the benefits of meta-analysis by comparing it to looking at
individual pixels versus looking at the overall picture from a distance. Aggregating the
data from all the studies of varying samples, methods, and conditions allows for
“smoothing the resulting picture into a composite, much as a magazine picture looks
more crisp and coherent at arms length than when the pixels are examined through a
magnifying glass” (Lipsey & Wilson, 2001, p. 167).
Chapter 2 Summary
Most studies of the psychometric properties of the DAST-20 concluded the
instrument yielded reliable and valid scores among various populations. However,
multiple optimal cutoff scores were reported, and findings of various factor analyses and
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diagnostic validity studies (sensitivity, specificity), and internal consistency values
differed. Many of the studies used homogeneous samples in a specific setting, which
limit the generalizability of the findings. The purpose of the current study is to examine
the findings from all of the identified studies and analyze the aggregated data to provide
insight on the overall psychometric properties of the DAST-20 scores and then discuss
implications for researchers and clinicians using the DAST-20 with various populations.
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CHAPTER 3: METHODOLOGY
Research Design
Psychometric synthesis procedures outlined by Erford et al. (2015) were used to
quantitatively examine the psychometric properties of the DAST-20 (Skinner, 1982a).
Although the research design is modeled on the study named above (Erford et al., 2015),
the correct classification of this research design is called a psychometric synthesis. A
psychometric synthesis has many procedural characteristics in common with a metaanalysis. However, in recent years, very specific procedures define a meta-analysis
(Lipsey & Wilson, 2001). Therefore, the article this study models is more correctly
classified as a psychometric synthesis. The procedures in a psychometric synthesis are
included in a meta-analysis, however not all procedures of a meta-analysis are included in
a psychometric synthesis.
A synthesis is conducted by following specific steps to examine the findings of
empirical studies that have produced results on a common subject of research (Erford et
al., 2015). This research design involves collecting all possible data from studies
examining a common research question that meet the established criteria of the study and
using particular statistical procedures to summarize these findings. This includes
establishing criteria for article inclusion, searching for relevant articles, examining
articles for criteria and completing the selection process, data extraction, and data
analysis. This psychometric synthesis will examine the reliability and validity of the
DAST-20 scores, combining the results of numerous articles that report data for the
instrument. After selecting the studies used in the psychometric synthesis, analyses were
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conducted on the reported results to produce a more comprehensive understanding of
outcomes.
Procedure
The procedure utilized in this study was outlined by Erford et al. (2015) in a
psychometric synthesis study that examined the psychometric properties of the Beck
Depression Inventory – Second Edition (BDI-II; Beck et al., 1996). The procedure
includes specific methods for searching for and identifying potential articles for inclusion
in the study, accepting or rejecting these studies, extracting data, and analyzing the data.
These procedures are described in detail below.
Article Selection and Criteria
A search for sources that contained psychometric data on the DAST-20 was
conducted. The search for relevant sources included published journal articles as well as
unpublished documents, such as dissertations, theses, and other unpublished sources that
were available through research databases, including all possible sources of psychometric
data on the DAST-20 into the study, reduced potential publication bias (Erford et al.,
2015).
Lipsey and Wilson (2001) identified several areas of eligibility criteria that apply
to most meta-analyses, including “distinguishing features, research respondents, key
variables, research methods, cultural and linguistic range, time frame, and publication
type” (pp. 16-17). Candidate articles selected for inclusion in the current study were
published or available between 1982 and 2014 (the year this study was started). For the
purposes of this study, more current studies will not be added, however, any articles
published between 2015 and 2021 will be included before this manuscript is submitted
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for publication. Selection for inclusion also required the use of the English version of the
shortened 20-item form of the DAST (DAST-20) and at least one psychometric property
of the DAST-20 reported, including internal consistency, test-retest reliability,
convergent validity, structural validity, diagnostic validity, and descriptive statistics.
Studies that reported means or standard deviations of the DAST scores were only
included if data were collected from nonclinical samples.
Search Procedures
The initial search for included sources was conducted through research databases,
including PsychINFO, ERIC, Academic Search Premier, MEDLINE, and Cochrane
Database of Systematic Reviews using the search text “Drug Abuse Screening Test” from
dates 1982 (the year the DAST was published) to 2014. To ensure all relevant data was
included in the analysis, a second search was conducted of the reference list of any source
that reported psychometric data. This redundant procedure was undertaken to obtain
potential sources that were not included in the original electronic search. Also, to make
sure data from a particular study was only used once in the data analysis, the list of
articles was searched for repeated occurrences. For example, dissertations and articles
resulting from a dissertation were analyzed for relevant psychometric data, but the
sample result was only used once to maintain independence of results. Once all the
articles were obtained through the multi-step search process, the selection process was
started.
Selection Process
The full text version of all articles identified by the search process were obtained
and numbered to organize selection procedures. The selection process was independently
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conducted by the author and two additional research assistants in order to ensure accurate
inclusion and rejection decisions of each article. The inclusion criteria listed above were
used to evaluate each article to determine whether or not the study provided usable data
for analysis. A further description of the psychometric variables of interest is provided
below. Each researcher inserted an independent decision for inclusion of each article in a
chart. If the decision was to accept an article for inclusion in the study, a short description
of the data of interest was included in the chart. A final compiled chart was completed,
listing each researcher’s decision for inclusion of each article. An inter-rater agreement
percentage was calculated at 95%. Ultimately, the decision to include or exclude articles
that were not agreed upon by the selectors was deferred to Dr. Erford, who has completed
many psychometric syntheses and has published on the research design.
After the selection process was finalized, data was extracted from all articles
accepted for inclusion. To ensure that aggregated data from a particular study was only
represented in the data analysis once, duplicative articles were rejected and dissertations
and articles using the same sample were used only once so the resulting data would
maintain independence.
Psychometric Variables Analyzed
The psychometric variables of interest for the analysis of this study included data
on internal consistency, test-retest reliability, convergent validity, structural validity,
diagnostic validity, and the means and standard deviations of nonclinical samples.
Reliability statistics of interest included internal consistency coefficients and test-retest
reliability data. Internal consistency refers to how well a set of items on an assessment
inter-correlate or hang together (Erford, 2021). Because responses to the DAST-20 are
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dichotomous (yes-no), Kuder-Richardson formula 20 (KR-20) was the most common
statistic used to examine the internal consistency of the DAST-20. Test-retest reliability
statistics represent the degree of consistency of an individual’s responses on an
instrument when administered twice. Pearson r is the statistic most commonly used to
examine test-retest reliability of the DAST-20. The time lapsed between the first and
second administrations of the DAST-20 was noted for each eligible study.
Multiple validity statistics were examined to determine the ability of the DAST20 in accurately measuring the construct of interest (Erford, 2021). Validity measures of
interest in the current psychometric synthesis included measures of convergent and
diagnostic validity (i.e., overall accuracy, sensitivity, specificity, positive predictive
power, negative predictive power), and structural validity (i.e., confirmatory factor
analysis, exploratory factor analysis). Construct validity refers to the ability of an
instrument to accurately measure the construct of interest, such as by providing statistical
evidence on convergent and discriminant validity. In the current study, articles were
screened for convergent validity statistics on the DAST-20. Convergent validity helps to
determine whether an instrument demonstrates adequate construct validity by statistically
comparing it with scores on other instruments measuring the same or a very similar
construct. If a high positive correlation is found between the two instruments, it is an
indication that the instrument under question demonstrates construct validity. In the
current psychometric synthesis study, Pearson r was normally the statistic used to
examine convergent validity.
Diagnostic validity refers to the ability of an instrument to accurately determine
the presence or absence of a specific diagnosis or condition. In order to determine the

39

diagnostic validity of an instrument, the scores of the instrument are compared to the
findings of a clinical evaluation or diagnosis of an individual completed by a mental
health professional (Erford, 2021). Although the DAST-20 is a screening instrument and
is not intended as a diagnostic assessment, it is still important that the instrument
accurately identifies individuals who most likely have an issue with drug abuse to allow
appropriate and timely referral for further evaluation, as needed. In the initial
examination of the DAST-20, Skinner (1982b) recommended a cutoff score of six for
screening purposes. Data of interest on the diagnostic validity of the DAST-20 included
the percent of individuals correctly classified overall by the instrument, specificity
values, sensitivity values, positive predictive values, and negative predictive values.
The test cutoff score and the criterion cutoff determined for the clinical evaluation
are used to examine these various indices of diagnostic validity (Erford, 2021). These
indices include sensitivity, specificity, positive predictive power, and negative predictive
power. Sensitivity refers to the ratio of true positives identified by the instrument cutoff
(individuals correctly identified to have a problem with drug abuse) out of all the
individuals identified to have a problem with drug abuse by the criterion cutoff
determined by the clinical evaluator (true positives plus false negatives of the
instrument). Specificity refers to the ratio of true negatives identified by the instrument
cutoff (individuals correctly identified to not have a problem with drug abuse) out of all
the individuals who were determined not to have a problem with drug abuse by the
criterion cutoff determined by the clinical evaluator (true negatives and false positives of
the instrument). Positive predictive power refers to the instrument’s ability to predict the
presence of a drug abuse problem. This statistic is determined by calculating the ratio of
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true positives identified by the test out of all the individuals identified by the test to have
a problem with drug abuse (true positives plus false positives). Finally, negative
predictive power refers to the instrument’s ability to predict the absence of a drug abuse
problem. This statistic is determined by calculating the ratio of true negatives (individuals
correctly identified to not have a problem with drug abuse) out of all the individuals the
instrument determined not to have a problem with drug abuse (true negatives plus false
negatives).
Structural validity is determined by using a statistical process called factor
analysis to examine the format of an instrument and to group related items into various
aspects of a construct by identifying which items correlate with each other (Erford,
2021). Each group of related items represents a factor. Studies of both exploratory factor
analysis (EFA) and confirmatory factor analysis (CFA) were of interest. An EFA is the
process of examining structural validity when evidence of the number of factors and how
items are grouped among factors is not available (Erford, 2021). In this process, the
factors that represent various constructs and the items that comprise the various factors
are determined by mathematical procedures. A CFA is the process of examining
structural validity when theoretical evidence is used to identify the number of factors
thought to be present and how the items load on each factor prior to the analysis.
Descriptive statistics, including means and standard deviation values, were also
extracted for analysis. Only means and standard deviations reported on nonclinical
samples were analyzed as data from clinical samples are not likely to represent the
general population parameters.
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The data extraction process was completed by creating tables for each
psychometric property identified in the articles. For example, one table was created to
record all articles that reported internal consistency values of the DAST-20, including the
article number, sample size (n), type of sample (nonclinical or clinical), and the KR-20
coefficient. If a value was also reported specifically for men or women, these values were
also stratified. Once the relevant data were extracted, analytic procedures were used to
examine the psychometric properties of the DAST-20.
Data Analysis
Research Questions
The following research questions were explored:
1. What are the aggregated psychometric properties of the DAST-20 scores (i.e., internal
consistency, test-retest reliability, diagnostic validity, structural validity, convergent
validity)?
2. What are the aggregated mean scores and standard deviations of the DAST-20 in
nonclinical samples?
3. Are there significant differences in the psychometric properties of the DAST-20
scores among various sample characteristics?
Statistical Analysis
Statistical analyses were conducted on the reliability and validity data described
above. All of the data included in the study were independent, which means that all data
were only represented in the study once (Erford et al., 2010). When completing the article
selection and data extraction processes, duplicate articles were deleted, and data sets
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published in more than one accepted article were used only once in the data aggregation
and analysis.
Before aggregation, all data were weighted by the corresponding sample size
before being analyzed in order to reduce sample size bias (Erford et al., 2015). According
to classical test theory, an observed score is comprised of the true score and an error of
measurement (Erford, 2021). The error of measurement is assumed to be random. As a
result, the average of the observed scores converges on the true score because they are
likely normally distributed. Therefore, internal consistency coefficients were weighted by
sample size and then averaged together to get aggregated reliability data. This process
was repeated for test-retest reliability aggregations. When interpreting the reliability
coefficient, coefficients .80 and higher are considered to be acceptable for screening
purposes and coefficients of .90 and above are acceptable for diagnostic purposes.
Unlike analysis of the reliability statistics, validity coefficients cannot be analyzed
by operating under the assumption of true score and error variance because systematic
error must be considered (Erford, 2021; Erford et al., 2015). Therefore, Pearson r
coefficients were converted to z-values before being weighted by sample size and
1

aggregated using the equation proposed by Hedges and Olkin (1985), 𝑧𝑧 (𝑟𝑟 ) = log[
2

1+𝑟𝑟

1−𝑟𝑟

For each convergent validity comparison, the Pearson r statistic was converted to a z-

].

score, then weighted by sample size and averaged. Finally, the averaged z-scores were
converted back to Pearson r coefficients. To interpret the Pearson r coefficients, the
following effect sizes were used, as recommended by Lipsey and Wilson (2001): 0.1
signifies a small effect size, 0.3 signifies a medium effect size, and 0.5 signifies a large
effect size.
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Evidence of diagnostic validity, as described above, was aggregated as possible
across the indices of percent of correct classifications, specificity values, sensitivity
values, positive predictive values, and negative predictive values. For each cut off score
on a similar criterion, index values were weighted by sample size, aggregated, and then
averaged. Evidence of structural validity was extracted from the accepted articles and
reported in table format. Finally, means and standard deviations of nonclinical samples
were weighted by sample size and averaged across studies.
Chapter 3 Summary
In chapter 3, the methodology for this study was reviewed. The research design
for this study is a psychometric synthesis, which uses specific procedures to collect and
analyze psychometric data from available research on a given topic of interest. The
procedures include setting criteria, completing an article search, screening articles for
inclusion in the study, data extraction, and data analysis. Data analysis was conducted on
reliability data (internal consistency, test-retest reliability), validity data (convergent
validity, structural validity, diagnostic validity), and means and standard deviations of
nonclinical samples. The data analysis and findings will be provided in chapter 4.
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CHAPTER 4: RESULTS
Introduction
Psychometric synthesis procedures (Erford et al., 2015) were conducted and the
available data on the psychometric properties (i.e., internal consistency, test-retest
reliability, convergent validity, structural validity, diagnostic validity, descriptive
statistics) of the DAST-20 (Skinner, 1982a) were analyzed as outlined in Chapter 3. In
this chapter, the results of the article search and selection are reported and a detailed
report of the data and analysis procedures are provided.
Sample
A total of 839 articles were produced by the electronic database search and 14
additional articles were found by hand searching candidate article reference lists,
resulting in a total of 853 potential articles screened for the study. In order to be selected
for inclusion into the study each article had to be in English, published between 1982 and
2014, use the English version of the 20-item DAST, and report at least one type of data
on the psychometric properties of the instrument. The selection process produced a total
of 56 articles accepted into the psychometric synthesis. Out of the 56 articles, 34 articles
provided data on internal consistency, three articles provided data on test-retest
reliability, 17 articles provided data on convergent validity, three articles provided data
on factor analysis, seven articles provided data on diagnostic validity, and 12 studies
provided mean and standard deviation descriptive statistics on the DAST-20 for
nonclinical samples.
The author and a committee member screened each of the 853 articles for relevant
data and the required criteria for inclusion into the study. The interrater agreement for
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article selection and inclusion was 94.8%, an inter-rater correlation of r = .851 (p < .001),
both indicators of strong inter-rater concordance (Erford, 2021). Any disagreement in
inclusion decisions were discussed until consensus was achieved.
DAST-20 Reliability
In the present study, data on the reliability of the DAST-20 scores was collected,
including evidence of internal consistency (i.e., KR-20) and test-retest reliability (i.e.,
Pearson r). The results are summarized below.
Internal Consistency
A total of 33 articles (j = 33) accepted into the current study provided internal
consistency data (KR-20). One of these articles included coefficient alpha values for three
independent sample groups, resulting in a total of 35 internal consistency scores included
in the aggregation (k = 35) and a total sample size of 15,546 (see Table 1). Each KR-20
was weighted by the corresponding sample size. The aggregated total DAST-20 internal
consistency for this study embedded within a 95% confidence interval was KR-20 =
.819[.819, .820].
Table 1: Total Aggregated Internal Consistency
Article
Aubry et al. (2012)

N
329

KR-20
.93

N x KR-20
305.97

Bliss et al. (2008)

178

.91

161.98

Boyd et al. (2009)

142

.96

136.32

Brocato & Wagner (2008)

141

.75

105.75

Burnett et al. (2013)

1,874

.78

1461.72

Cassidy et al. (2008)

84

.998

83.832

Cocco & Carey (1998)

97

.92

89.24

Fineran et al. (2010)

200

.91

182.00

Fleury et al. (2012)

2,443

.74

1807.82

Forbey et al. (2008)

1,038

.81

840.78

Forbey et al. (2011)

213

.95

202.35
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Forbey et al. (2013) sample a

1,065

.81

862.65

Forbey et al, (2013) sample b

613

.93

570.09

Forbey et al. (2013) sample c

164

.94

154.16

Irving & Schweiger (1991)

400

.77

308.00

Kaslow et al. (2006)

274

.94

257.56

Kimbrel et al. (2011)

162

.77

124.74

Looman & Abracen (2013)

348

.90

313.20

Mowbray et al. (2006)

379

.94

356.26

Murphy et al. (2007)

139

.90

125.10

Nelson et al. (2011)

1,637

.77

1260.49

Nochajski et al. (2013)

520

.82

426.40

Nordfjærn (2013)

203

.795

161.385

Perepletchikova et al. (2012)

99

.96

95.04

Reviere et al. (2007)

200

.92

184.00

Rosenkranz, Muller et al. (2012)

216

.71

153.36

Rosenkranz, Henderson et al. (2012)

188

.72

135.36

Saltstone et al. (1994)

318

.88

279.84

Skinner (1984)

223

.94

209.62

Skinner & Goldberg (1986)

105

.74

77.70

Stuart & Holtzworth-Munroe (2005)

86

.91

78.26

Sullivan et al. (2009)

412

.86

354.32

Teslak (2000)

142

.90

127.80

Weber (2008)

824

.81

667.44

Weinstein (1999)

90

.88

79.20

15,546

Total

12,739.737

A total of seven articles (j = 7) accepted into the current study provided internal
consistency data (KR-20) for female participants. The articles resulted in a total sample
size of 1,903 (see Table 2). Each coefficient α was weighted by the corresponding sample
size. The aggregated total DAST-20 internal consistency for females was KR-20 =
.909[.846, .954].
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Table 2: Internal Consistency - Females
Article
Bliss et al. (2008)

N
178

KR-20
.91

N x KR-20
161.98

Boyd et al. (2009)

142

.96

136.32

Kaslow et al. (2006)

274

.94

257.56

Mowbray et al. (2006)

379

.94

356.26

Reviere et al. (2007)

200

.92

184.00

Saltstone et al. (1994)

318

.88

279.84

Sullivan et al. (2009)

412

.86

354.32

1,903

Total

1,730.28

A total of seven articles (j = 7) accepted into the current study provided internal
consistency data (KR-20) for male participants. One article provided two samples,
resulting in a total of eight internal consistency values that were aggregated (k = 8). The
articles resulted in a total sample size of 1,846 (see Table 3). Each coefficient was
weighted by the corresponding sample size. The aggregated total DAST-20 internal
consistency for males was KR-20 = .908[.862, .954).
Table 3 – Internal Consistency - Males
Article
Brocato & Wagner (2008)

N
141

KR-20
.75

N x KR-20
105.75

Forbey et al. (2011)

213

.95

202.35

Forbey et al. (2013) sample b

613

.93

570.09

Forbey et al. (2013) sample c

164

.94

154.16

Looman & Abracen (2013)

348

.90

313.20

Murphy et al. (2007)

139

.90

125.10

Stuart & Holtzworth-Munroe (2005)

86

.91

78.26

Ting (2009)

142

.90

127.80

1,846

Total

1,676.71

A total of six articles (j = 6) accepted into the current study provided internal
consistency data (KR-20) for nonclinical samples. One article provided two samples,
48

resulting in a total of seven aggregated internal consistency values (k = 7). The articles
resulted in a total sample size of n = 7,319 (see Table 4). Each KR-20 was weighted by
the corresponding sample size. The aggregated total DAST-20 internal consistency for
the nonclinical samples was KR-20 = .793[.770, .816].
Table 4 – Internal Consistency – Nonclinical Samples
Article
Burnett et al. (2013)

N
1,874

KR-20
.78

N x KR-20
1,461.72

Fineran et al. (2010)

200

.91

182.00

Fleury et al. (2012)

2,443

.74

1,807.82

Forbey & Ben-Porath (2008)

1,038

.81

840.78

Forbey et al. (2013) sample a

1,065

.81

862.65

Forbey et al. (2013) sample b

613

.93

570.09

Stuart & Holtzworth-Munroe (2005)

86

.91

78.26

7,319

Total

5,803.32

Clinical sample results were also aggregated and included a total of 28 articles
and studies (j = 28; k = 28) accepted into the current study that provided internal
consistency data (KR-20) for clinical samples. The articles resulted in a total sample size
of 8,227 (see Table 5). Each coefficient was weighted by the corresponding sample size.
The aggregated total DAST-20 internal consistency for clinical samples was KR-20 =
.843[.821, .865].
Table 5 – Internal Consistency – Clinical Samples
Article
Aubry et al. (2012)

N
329

KR-20
.93

N x KR-20
305.97

Bliss et al. (2008)

178

.91

161.98

Boyd et al. (2009)

142

.96

136.32

Brocato & Wagner (2008)

141

.75

105.75

Cassidy et al. (2008)

84

.998

83.832

Cocco & Carey (1998)

97

.92

89.24
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Forbey et al. (2011)

213

.95

202.35

Forbey et al. (2013) sample c

164

.94

154.16

Looman & Abracen (2013)

348

.90

313.20

Mowbray et al. (2006)

379

.94

356.26

Murphy et al. (2007)

139

.90

125.10

Irving & Schweiger (1991)

400

.77

308.00

Kaslow et al. (2006)

274

.94

257.56

Kimbrel et al. (2011)

162

.77

124.74

Nelson et al. (2011)

1,637

.77

1,260.49

Nordfjærn (2013)

203

.795

161.385

Nochajski et al. (2013)

520

.82

426.40

Perepletchikova et al. (2012)

99

.96

95.04

Reviere et al. (2007)

200

.92

184.00

Rosenkranz, Muller et al. (2012)

188

.72

135.36

Rosenkranz, Henderson et al. (2012)

216

.71

153.36

Saltstone et al. (1994)

318

.88

279.84

Skinner (1984)

223

.94

209.62

Skinner & Goldberg (1986)

105

.74

77.70

Sullivan et al. (2009)

412

.86

354.32

Ting et al. (2009)

142

.90

127.80

Weber (2008)

824

.81

667.44

Weinstein (1999)

90

.88

79.20

8,227

Total

6,936.417

Test-retest Reliability and Other Measures of Consistency
Only one article included in the current study reported data on test-retest
reliability. Peters et al. (2000) reported a test-retest reliability value (rtt) of .95[.70, 1.00;
n = 60] with a 72-hour period between test administrations.
Somewhat relatedly, Cocco and Carey (1998) reported intraclass correlations with
an ICC value of .78[.58, .98; n = 97]. The period of time between test administrations
was between 7-43 days depending on the participant.
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In addition, Conner et al. (2004) reported an interrater reliability of .62[.34, .90; n
= 48] between a participant’s self-report and their partner’s report of the participant’s
drug abuse.
DAST-20 Validity
Data on the score validity of the DAST-20 was collected, including evidence of
convergent validity (i.e., Pearson r), structural validity (i.e., confirmatory factor analysis,
exploratory factor analysis), and diagnostic validity (i.e., overall accuracy, sensitivity,
specificity, positive predictive power, negative predictive power). The results are
summarized below.
Convergent Validity
Evidence of convergent validity was most commonly reported as Pearson r
coefficients. A total of 17 articles reported convergent validity data on the DAST-20.
Only two instruments (not including correlations between the DAST-20 and other forms
of the DAST) were used in multiple studies and aggregated. The first instrument reported
in multiple studies is the Michigan Alcoholism Screening Test (MAST; 25-items) (see
Table 6). A total for four studies (j = 4; k = 4), with a combined sample size of 766,
included Pearson r values between the DAST-20 and the MAST (25-item version). Three
of the four studies reported a positive correlation between the MAST and the DAST-20
and one study (Gavin et. al, 1989) reported a negative correlation between the two
instruments. After converting each Pearson r value to z-values, weighting the value by
sample size (z x n), averaging the scores, and converting the aggregated z-score back to a
Pearson r value, the aggregated correlation was r = .11[.04, .18], a no to small effect size
(Cohen, 1988).
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Table 6 – Correlation with the Michigan Alcohol Screening Test (MAST; 25 items)
Article
Cocco & Carey (1998)
Gavin et al. (1989)
Marshall & Marshall (2006)
Weinstein (1999)
Total

N
97
501
80
88
766

r
.52
-.19
.56
.659

z-value
0.576
-0.192
0.633
0.793

zxn
55.872
-96.192
50.64
69.784
80.104

The second instrument that had multiple correlation coefficients reported (j = 2; k
= 2; n = 6,504) with the DAST-20 is the Alcohol Dependence Scale (ADS) (see Table 7).
Similar to the MAST (25-item) correlation, Gavin et al. (1989) found a negative
correlation between the DAST-20 and the ADS, while Shuggi et al. (2006) reported a
positive correlation between the two instruments. The aggregated convergent validity
value for the DAST-20 and the ADS is r = 0.27[.25, .29], a small to medium effect size.
Table 7 – Correlation with the Alcohol Dependence Scale
Article
N
r
Gavin et al. (1989)
501
-.13
Shuggi et al. (2006)
6,003 .30
6,504
Total

z-value
-0.131
0.310

zxn
-65.13
1,860.93
80.104

Although the ADS and the MAST (25-item) were the only instruments with
multiple correlation data with the DAST-20, a total of 27 additional instruments or
subscales had a single report of convergent validity data with the DAST-20. One study
(Møller & Linaker, 2010) reported phi coefficients, whereas all other articles reported r
values. Moller and Linaker (2010) reported a phi value of .41 (n = 37) for the ICD-10 and
the DAST-20 and a phi value of .34 (n = 37) for the DUS and DAST-20. The convergent
validity (r) data of the other instruments are reported in Table 8.
Table 8 – Additional Convergent Validity Correlations with DAST-20.
Article
Instrument
n
Alexander & Leung
Marijuana Screening Inventory (MSI-X)
107
(2006)
52

r
.531

Alterman et al. (2007)

2,142

.65

2,142
141

.63
.66

97

.42

97

.40

97
97
Males
407
Females
631
159

.33
-.14
.53

159

.35

159

.46

159
501

.45
.75

501

.74

501

-.31

501

-.25

90

.61

Obsessive Compulsive Cocaine Use Scale
(OCCUS) Total

107

.42

107
107
200

.27
.47
.54

Teslak (2000)

OCCUS - Obsessive
OCCUS – Compulsive
Michigan Alcoholism Screening Test (10item)
CAGE Drug Test (CAGE D)

70

.52

Weber (2008)

SASSI-2 Face Valid Other Drugs (FVOD)
AUDIT (10-item)

70
824

.49
.39

Brocato & Wagner
(2008)
Cocco & Carey
(1998)

Forbey et al. (2008)

Forbey et al. (2011)

Gavin et al. (1989)

Hall et al. (2007)
Hormes et al. (2012)

Reviere et al. (2007)

Addiction Severity Index – 5th Edition
(ASI-5) Recent Drug Problems
ASI-5 Lifetime Drug Problems
DSM-IV TR Checklist
Addiction Severity Index (ASI) – Drug
Composite Score
Clinician Rating Scales for Drug Use
(CRS-Drug)
ASI – Alcohol Composite Score
Global Assessment of Functioning (GAF)
MMPI-2-RC RC4 subscale – Antisocial
Behavior
Minnesota Multiphasic Personality
Inventory 2 (MMPI-2)
MMPI-2 MAC-R (MacAndrew Alcoholism
Scale-Revised)
MMPI-2 AAS (Addiction
Acknowledgement Scale)
MMPI-2 APS (Addiction Potential Scale)
DSM-III Drug Addiction Diagnosis
(Current)
DSM-III Drug Addiction Diagnosis
(Lifetime)
DSM-III Alcohol Addiction Diagnosis
(Current)
DSM-III Alcohol Addiction Diagnosis
(Lifetime)
Externalizing Inventory and Criterion
Measure (100-item)

53

.52
.52

Three articles provided convergent validity data on the DAST-20 and two other
forms of the DAST. Aggregated correlations between the DAST-20 and DAST-10 are
summarized in Table 9. Skinner (1984) produced a correlation with the DAST (28-items)
with a sample size of 223 of r = .99[.86, 1.00]. Two articles (see Table 9) produced
correlations with the DAST-10 (j = 2; k = 2) with a total sample size of 320. After
converting r values to z-values, weighting by corresponding sample sizes, and converting
the aggregated z-score back to an r value, the averaged correlation coefficient for the
DAST-20 and DAST-10 was r = .98[.87, 1.00].
Table 9 – Convergent Validity between DAST-20 and DAST-10
Article
N
r
Cocco & Carey (1998)
97
.97
Skinner (1984)
223
.98
320
Total

z-value
2.092
2.298

zxn
202.924
512.454
715.378

Structural Validity
Three articles provided evidence of structural validity, including one confirmatory
factor analysis (Cocco & Carey, 1998) and three exploratory factor analyses (Cocco &
Carey, 1998; Saltstone et al., 1994; Skinner & Goldberg, 1986). Varying findings are
reported below and implications discussed in Chapter 5.
Confirmatory Factor Analysis
Cocco and Carey (1998) performed a confirmatory factor analysis on the DAST20 administered to a sample of only 100 participants, resulting in a poor fit for the
unidimensional model (X2 = 473.23, p < .001; GFI = .72; AGFI = .65). With only 100
participants, this CFA was significantly underpowered.
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Exploratory Factor Analysis
Cocco and Carey (1998) reported a possible six-factor solution for the DAST-20.
However, after reviewing the factor loadings, in which the first factor accounted for 41%
of the variance and factors 2 through 6 accounted for an additional combined total of
30% of the variance, the researchers concluded that a two-factor solution best represented
the scale. Cocco and Carey (1998) reported factor 1 was composed of items that inquire
about “external consequences experienced by drug use,” which included all items except
for items 4 and 5 (factor loadings of .47 to .77) (p. 411). Factor 2 was comprised of items
4 (factor loading = .73) and 5 (factor loading = .55). These two items “had the lowest
item-scale correlations” (p. 411). However, with only 97 participants, this EFA was
significantly underpowered.
Saltstone et al. (1994) performed an exploratory factor analysis of DAST-20
scores from 615 female participants. This analysis resulted in a five-factor solution;
however, due to a small variance (.14) between the last two factors, Saltstone et al.
determined the four-factor solution was most parsimonious. A second factor analysis was
performed for four factors and accounted for 56% of the total variance. The first factor
alone accounted for 32.5% of the variance. Factor 1 was composed of items (4, 5, 7-11,
15, 16, 19, & 20) that inquire about drug abuse habits, social consequences, medical
consequences, and previous treatment. Factor 2 was composed of items (12 & 13) related
to work consequences. Similar to factor one, factor three comprised of items (2, 3, 6, 14,
17 & 18) that inquire about drug abuse habits, medical consequences, and “aggression,”
however different items loaded on factor 3 than on factor 1. Factor 4 included a single
item (1) that inquired about an individual’s drug dependence; single items do not

55

constitute a factor. In addition, items 4, 5, 17, & 18 displayed significant cross loading
between two factors.
The third article (Skinner & Goldberg, 1986) that explored structural validity
reported data from an exploratory factor analysis of the DAST-20 administered to 105
participants. The analysis resulted in a five-factor solution. Factor 1 was composed of
three items (items 4, 5, and 17) that inquire about an individual’s drug dependence.
Factor 2 was composed of six items (items 8 through 13) that inquire about social
consequences. Two items loaded on factor 3 (items 6 and 18), both of which inquire
about medical consequences related to drug abuse. Factor 4 included five items (items 1
through 3, 14, and 16) inquiring about one’s drug abuse habits and use, as well as legal
consequences. The two items (14 and 16) that addressed legal consequences did not load
as highly (.54 and .42, respectively). Finally, factor 5 had two items (items 19 and 20)
load that inquire about previous treatment. With only 105 participants, this EFA was
significantly underpowered.
Diagnostic Validity
A total of six articles reported diagnostic validity data for the DAST-20. Only two
of these articles could be aggregated because of diverse criterion measures and cutoff
scores. Therefore, a summary of the remaining articles is provided. Five of the articles
reported data for similar cutoff scores (see Table 10).
Table 10 – Diagnostic Validity Data with Comparative Cut-off Scores
Studies
n Cutoff % CC Sens Spec PPV NPV
Alexander & Leung
174
≥6
79.1
.818 .608
__
__
(2011)
Cassidy et al. (2008)
84
6
71
.55
.86
.79
.68

Criterion
DSM-G-CS
21
SCID

Cocco & Carey (1998)

97

5/6

81

.74

.83

__

__

DSM-HI-R

Gavin et al. (1989)

501

5/6

85

.96

.79

.73

.97

DSM-III
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Møller & Linaker
(2010)
Peters et al. (2000)

48

≥5

__

.86

.67

__

__

ICD-10

306

>6

82.7

.882

.805

.636

.947

SCID-IV

Alexander and Leung (2011; n = 174) reported a sensitivity of .818, a specificity
of .608, and 79.1% correctly classified for a cutoff score of 6 or greater. The criterion
used was the DSM-G-CS 21. Møller and Linaker (2010; n = 48) reported a sensitivity
value of .86 and a specificity of .67 for a cutoff score of 5 or greater. Cassidy et al. (2007;
n = 84) had optimal results at a cutoff score of 3 using the SCID as the criterion measure.
At this cutoff score, the sensitivity value was .85, the specificity value was .73, the PPV
was .74, and the NPV was .84, with 79% of participants correctly identified. However,
with the traditionally recommended cutoff score of 6, Cassidy et al. (2007) reported a
sensitivity of .55, a specificity of .86, a PPV of .79, a NPV of .68 and 71% of participants
were correctly classified. Coco and Carey (1998) reported diagnostic validity data on a
sample of 97 individuals using the DSM-HI-R criterion for drug use disorder. Optimal
sensitivity and specificity results were found with a cutoff score of 2/3 (sensitivity = .89,
specificity = .68, %CC = 72) and 5/6 (sensitivity = .74, specificity = .83, %CC = 81).
Using the DSM-III as the criterion measure, Gavin, et al. (1989; n = 501) found that the
percent of individuals correctly identified was 85 between the cutoff scores of 5/6 and
9/10. Sensitivity and specificity values were closest (.88 and .84, respectively) at a cutoff
score of 6/7. Finally, Peters et al. (2000; n = 306) reported diagnostic validity for the
DAST-20 for a cutoff score of 6 or greater using the SCID-IV as the criterion measure.
The sensitivity was .882, specificity .805, PPV .636, NPV .947, and 82.7% of individuals
were correctly classified.
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An aggregation of Coco and Carey (1998) and Gavin et al.’s (1989) diagnostic
validity data was completed (see Table 11) as the two studies reported cutoff scores in the
same format and used a version of the DSM as the criterion.
Table 11 – Aggregated Diagnostic Validity Data for Cocco and Carey (1998) and
Gavin et al. (1989) (n = 598, j =2)
Cutoff Score
Sensitivity
Specificity
%CC
0/1
1.00
.385
59.1
1/2
.992
.542
69.9
2/3
.982
.663
77.9
3/4
.974
.723
81.2
4/5
.957
.765
83.3
5/6
.924
.796
84.4
6/7
.881
.820
84.7
7/8
.831
.850
84.7
Descriptive Statistics
Means and standard deviations reported for nonclinical samples were extracted
and aggregated. A total of 12 articles (j = 12) included in the current study provided data
for nonclinical samples, with six articles providing data on multiple nonclinical groups (k
= 19). The combined total sample size was 2,617. Each mean and standard deviation was
weighted by sample size and aggregated. The total average mean is 1.083 and the total
average standard deviation is 1.620. These results are summarized in Table 12.
Table 12 - DAST-20 Descriptive Statistics of Nonclinical Samples
Article
N
M
NxM
Aubry et al. (2012)
89
0.0
0.0

SD
0.0

N x SD
0.0

Burnett et al. (2013) sample a

552

2.1

1,159.2

2.8

1,545.6

Burnett et al. (2013) sample b

1,322

1.1

1,454.2

1.7

2,247.4

Ersche et al. (2010) sample a

30

0.0

0.0

0.0

0.0

Ersche et al. (2010) sample b

30

0.4

12.0

1.0

30.0

Ersche et al. (2012) sample a

50

0.0

0.0

0.0

0.0

Ersche et al. (2012) sample b

50

0.5

25.0

1.1

55.0

Ersche et al. (2013) sample a

52

0.0

0.0

0.0

0.0
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Ersche et al. (2013) sample b

50

0.5

25.0

1.1

55.0

Fineran et al. (2010) sample a

79

0.23

18.17

0.97

76.63

Fineran et al. (2010) sample b

79

0.34

26.86

0.85

67.15

Fineran et al. (2010) sample c

7

0.14

0.98

0.38

2.66

Gizewski et al. (2013)

12

0.8

9.6

0.8

9.6

Levy (2013)

22

1.5

33.0

1.4

30.8

Morein-Zamir et al. (2013) sample a

39

.36

14.04

.74

28.86

Morein-Zamir et al. (2013) sample b

41

0.0

0.0

0.0

0.0

Schiffer et al. (2010)

14

0.9

12.6

0.9

12.6

St. Germain & Hooley (2012)

68

0.4

27.2

0.7

47.6

Weinborn et al. (2011)

31

0.5

15.5

1.0

31.0

2,617

Total

2833.35

4,239.9

Chapter 4 Summary
In this chapter, the results of the article search and selection were reported.
Further, the psychometric properties (i.e., internal consistency, test-retest reliability,
convergent validity, structural validity, diagnostic validity, descriptive statistics) of the
DAST-20 (Skinner, 1982a) were summarized. In Chapter 5, the results will be interpreted
and I will discuss the significance of the findings, limitations of the study, and
implications for future research.
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CHAPTER 5: DISCUSSION
Introduction
The current study examined the psychometric properties of the DAST-20
(Skinner, 1982a) following psychometric synthesis procedures outlined in Chapter 3.
Various factors in research studies can contribute to variations in reported psychometric
properties of the instrument, which can have an impact on how clinicians and researchers
use and interpret the results of the DAST-20 (Erford et al., 2010; Lipsey & Wilson,
2001). This is significant because researchers and clinicians are required to provide care
that is supported by research and ethical guidelines, including examining the
psychometric properties and empirical data of the instrument and considering
multicultural facets when using the instrument (ACA, 2014). This study aimed to provide
an overview and aggregated results of all relevant data on the DAST-20 in order to
provide a more comprehensive and clear picture of the psychometric properties of the
instrument.
This psychometric synthesis of the DAST-20 included data from 56 articles and
provided aggregated results of internal consistency, test-retest reliability, convergent
validity, structural validity, diagnostic validity, and descriptive statistics of the
instrument. Overall, the aggregated data produced adequate to excellent score reliability
coefficient values for a screening instrument. The validity data was more diverse, with
varying structural analysis reports and reported cutoff scores when examining diagnostic
validity. In this chapter, interpretation of the results from Chapter 4 and implications will
be discussed in detail. Then, limitations of the study, recommendations for clinicians, and
recommendations for future research will be provided.
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Research Questions
Three research questions formed the basis of this study:
1. What are the aggregated psychometric properties of the DAST-20 scores across
published studies (i.e., internal consistency, test-retest reliability, diagnostic
validity, internal structural validity, external convergent validity)?
2. What are the mean scores and standard deviations of the DAST-20 in nonclinical
samples across published studies?
3. Are there significant differences in the psychometric properties of the DAST-20
scores among various sample characteristics (e.g., gender)?
Discussion of Results
The first research question inquired about the aggregated psychometric properties
of the DAST-20 scores, including internal consistency, test-retest reliability, diagnostic
validity, structural validity, and convergent validity. When determining the efficacy of
internal consistency estimates, Erford (2021) recommended values of at least .80 to
consider scores from an instrument acceptable for screening purposes and at least .90 for
use as a diagnostic tool. From the initial psychometric examination of the DAST-20
scores, Skinner (1984) reported an excellent internal consistency for the total sample and
a good internal consistency for a subsample that omitted participants reporting only
alcohol abuse. Both of these estimates indicate that the DAST-20 is adequate for
screening purposes, although, the subsample size is small. The internal consistency
estimate of the subsample, which included individuals who reported only drug abuse or
drug abuse and alcohol abuse and omitted those who reported only alcohol abuse is likely
to be more similar to the current sample because the DAST-20 instructions specify that
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the items do not inquire about alcohol use. The aggregated internal consistency value
from the current study was slightly lower than the initial subsample, although still
indicative of an adequate reliability for a screening instrument.
Of the studies included in this study that reported internal consistency values,
there was a disparity between sample size and KR-20 values. Samples that were over
1,000 participants had lower internal consistency estimates than the studies with a smaller
sample size. All of these larger studies, except for one consisted of a nonclinical sample.
Therefore, the lower internal consistency scores among these studies can be attributed to
homogeneity of scores, as nonclinical samples tend to have a very large percentage of
low scores with many individuals scoring 0 on the instrument.
Out of the 33 articles reporting internal consistency data, seven articles provided
data for female participants (see Table 2) and seven articles provided data for male
participants (see Table 3). The aggregated data was consistent among males and females
and provided evidence of excellent internal consistency for females and males scores.
The internal consistency estimates for gender groups were significantly higher than for
the total sample, but they included a much smaller sample size.
The sample also was divided into clinical and nonclinical subsamples in order to
assess internal consistency estimate differences between the two groups. The aggregated
internal consistency score estimate for the clinical subsample was slightly higher than the
estimate for the overall sample (see Table 5). The internal consistency estimate calculated
for the nonclinical subsample was significantly lower (see Table 4). This estimate falls
just below the cutoff considered adequate for screening tests.

62

Only two articles reported evidence of test-retest reliability for the DAST-20
scores and each of the studies reported different types of evidence and varying
timeframes of test administration, which did not allow for aggregation of the data. Peters
et al. (2000) reported excellent test-retest score reliability over a period of 72 hours.
Although the sample was small, the results indicate more than adequate test-retest
reliability of the DAST-20 scores for screening purposes over a 72-hour timeframe.
Cocco and Carey (1998) reported evidence of lower test-retest reliability. Again, the
sample size was under 100 participants and the timeframe between test administrations
was inconsistent in that study (readministering the test anywhere between 7 to 43 days for
each participant). The inconsistency of test administration could have had an effect on the
reported reliability. Further, the longer gap between test administrations could contribute
to the lower reliability scores (Bressler et al., 2018). Finally, Conner et al. (2004)
reported interrater reliability between the participant’s self-report of drug abuse and their
significant other’s report of the participant’s drug abuse using the DAST-20. The sample
size of this study is smaller than what is considered ideal.
Evidence of convergent validity among scores from included studies ranged from
-.13 to .75 depending on the instrument being correlated with the DAST-20. The MAST
(25-items; see Table 6) and the ADS (see Table 7) were the only two instruments with
multiple convergent validity data reported in multiple studies. The aggregated convergent
validity estimate for both the MAST and the ADS indicated small correlations. Both
convergent instruments measure problems related to alcohol use, whereas the DAST-20
excludes alcohol when assessing drug abuse. Among the other 27 instruments (see Table
8) with one source of data of convergent validity with the DAST-20 scores, six
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instruments or subscales measured alcohol use, including the Alcohol Composite Score,
the MMPI-2 MAC-R, the DSM-III Alcohol Addiction Diagnosis current and lifetime, the
MAST (10-item), and the AUDIT (10-item). All of the convergent validity estimates
indicated medium to large correlations (effect sizes) between the DAST-20 and each
instrument scores.
These estimates may support the ability of the DAST-20 scores to discriminate
between alcohol abuse and drug abuse during the screening process. Medium to strong
correlation values were reported for the DAST-20 and the Marijuana Screening Inventory
(MSI-X), the Addiction Severity Index - Recent Drug Problems (ASI-5) and Lifetime
Drug Problems, Addiction Severity Index – Drug Composite Score, Clinician Rating
Scales for Drug Use, DSM-III Drug Addiction Diagnosis - Current and Lifetime,
Obsessive Compulsive Cocaine Use Scale – Total, the CAGE Drug Test, and the SASSI2 Face Valid Other Drugs. These estimates support convergent validity between the
DAST-20 scores and other instruments measuring drug abuse, yielding medium to large
effect sizes (Cohen, 1988).
Cocco and Carey (1998) reported a negative, small convergent validity estimate
between the DAST-20 and the Global Assessment of Functioning (GAF). As discussed in
Chapter 2, drug abuse has been shown to result in negative consequences in various
aspects of an individual’s life. Therefore, it seems logical that as scores increase on the
DAST-20 (indicating more consequences of drug abuse) then scores on the GAF would
decrease (indicating lower levels of functioning in various aspects of life).
Finally, multiple studies reported evidence of convergent validity between the
DAST-20 and other forms of the instrument. Skinner (1984) reported a strong correlation
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between the DAST (28-items) and the DAST-20. Aggregated convergent validity data for
the DAST-20 and the DAST-10 indicated a strong, positive correlation. These findings
suggest that clinicians and researchers should chose the form of the instrument based on
the recommended uses. For example, The DAST-20 is recommended for use in clinical
settings and for research evaluation (Skinner, 1984).
Varying findings were reported for the structural validity of the DAST-20. Cocco
and Carey (1998) was the only study that performed a confirmatory factor analysis based
on the original finding of a one-factor solution, with an undersized sample. EFA and CFA
typically requires 10 participants per item to yield reliable results (Tabachnik & Fidell,
2019). At 100 participants for 20 items, the analyses were significantly underpowered.
Cocco and Carey decided to run an exploratory factor analysis after the confirmatory
factor analysis did not support a one-factor solution.
Three studies performed an exploratory factor analysis on the DAST-20 and all
three studies came to different conclusions. Cocco and Carey (1998) reported a twofactor solution, Saltstone et al. (1994) reported a four-factor solution, and Skinner and
Goldberg (1986) reported a five-factor solution. Differences in sample characteristics and
the primarily small sample sizes could have affected the factor analysis results of the
instrument. Two of these three studies were underpowered with sample sizes of 97 and
105 and each consisted of about 75% males and 25% females. The study conducted by
Saltstone et al. (1994) was not underpowered, however the sample consisted of only
females. It also appears that some of the items had significant cross-loading on multiple
factors with less than .1 difference. This could affect the interpretation of the loadings.
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Unfortunately, from the available data, a preliminary conclusion of an EFA factor
solution of the DAST-20 cannot be made and further research is needed.
Diagnostic validity of the DAST-20 was analyzed, including examining percent
correctly classified, sensitivity, specificity, positive predictive values, and negative
predictive values. Adequate data was not reported in most of the articles reporting on
diagnostic validity of the instrument. Skinner (1982a) originally recommended a cutoff
score of 6 or greater to determine an individual’s need for further evaluation of drug
abuse, but also specified that more research needed to be completed. Multiple articles
provided data for a cutoff of 5/6 or greater, with a range of 71 to 85 percent correctly
classified. This range was used following the recommendation of Skinner (1982a) and
did not provide further statistics for other cutoff scores. Therefore, it is not possible to see
if there were more optimal cutoff scores for these studies. The six studies also used
different criterion measures (i.e., various DSM versions, ICD). Due to the lack of data
and differences in criteria, only two studies (Cocco & Carey, 1998; Gavin et al., 1989)
provided enough data using similar criterion measures to be aggregated. The results of
this aggregation is in agreement with Skinner’s (1982a) original cutoff recommendation,
with a maximum percent correctly classified of 84.7 at a cutoff score of 5/6 and higher.
However, Cocco and Carey (1998) independently reported optimal sensitivity and
specificity results at a cutoff of 2/3. The sample size of Cocco and Carey’s study was
significantly smaller than the second study accounting for only 97 of the 598 individuals
in the study and, therefore had less impact on the overall findings. Cassidy et al. (2007)
reported an optimal cut-off of 3. These lower cut-off scores are in agreement with the
data collected for the second research question of this study.
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The second research question inquired about the mean scores and standard
deviations of the DAST-20 among nonclinical samples. The total average mean of
nonclinical samples is 1.083 with an average standard deviation of 1.620 (see Table 10).
In 2015, the NIH reported that four percent of adults in the United States met the criteria
for a diagnosis of drug abuse disorder within the last year. Using this statistic, the DAST20 cut-off score at the 96th percentile is about 3.9. This lower cut-off score is more
congruent with the studies mentioned above. More research is needed to examine optimal
cut-off scores, but the tentative conclusion is that a cutoff score of 6, as previously
recommended by Skinner (1982a) is too high to effectively and accurately identify all
individuals who need further assessment for drug abuse. A cutoff score of four appears to
be a more acceptable cut-off score, leading to fewer false negatives when screening for
substance abuse.
Finally, the third research question inquired about the presence of significant
differences in psychometric properties of the DAST-20 among various sample
characteristics. Due to a lack of available data reported in the accepted publications,
gender was the only sample characteristic that could be examined. The aggregated data
for internal consistency was consistent among males and females and provided evidence
of excellent internal consistency for females and males. Only a fraction of the included
articles that reported on internal consistency provided scores for males and females,
which contributes to the higher scores compared to the overall internal consistency
estimates. Unfortunately, none of the studies that included nonclinical samples provided
mean and standard deviations values for only males or females.
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Limitations
As mentioned in Chapter 1, there were several delimitations prior to conducting
the study that should be noted. One category of delimitations concerns data available
during the time of the study. Only articles that were published in English and used the
English version on the DAST-20 were considered for inclusion in this study. Therefore,
potential relevant data from studies published in other languages could not be included
(Lipsey & Wilson, 2001). Similarly, this psychometric synthesis only included articles
that reported data from the 20-item version of the DAST, meaning that the results of this
study should only be used to guide one’s use of the English version of the DAST-20.
Further, this study is limited by the available data provided by included studies. Although
the full text version of each potential study was examined for relevant psychometric data
on the DAST-20, we were limited by what was included in the published articles.
Therefore, without access to more detailed records, relevant data that could affect the
overall aggregated results of the current study are potentially missing. The current study
only includes articles that were published between 1982 (the year the DAST was
published) and 2014 (the year that the current study was originally started). Seven years
of recent studies need to be searched and included before publication of the results.
The second category of delimitations include the general limitations and
criticisms of meta-analyses and similar types of studies such as this study (Erford et al.,
2015; Lipsey & Wilson, 2001). When completing a synthesis or meta-analysis, specific
factors of the individual studies may become lost or unnoticed in the overall analysis.
Critics of synthesized methodologies argue that these factors, such as limitations, cultural
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implications, theoretical frameworks, and study quality, can have important implications
that are not always able to be highlighted and examined in a large aggregation of studies.
A further limitation of this study was the lack of psychometric data reported for
specific groups, such as race, ethnicity, different age groups, and so on. Therefore, data
aggregation was not possible for diverse groups. Gender (male/female) was the only
group that had sufficient reported data to complete analyses, but this was still somewhat
limited. Mean and standard deviations of nonclinical samples were not available across
gender, which impeded the ability to assess gender score differences.
Validity data in general was very limited for the DAST-20. There were only three
available studies that reported evidence of EFA and one study that reported evidence of
CFA. Evidence of diagnostic validity was only provided in six studies and there were
only two instruments that had multiple convergent validity values with the DAST-20 that
could be aggregated. All of the other instruments that had convergent validity scores with
the DAST were only reported in one study. There were also no measurement invariance
studies available to examine item response differences among various groups. The lack of
data made it difficult to examine, interpret, and draw conclusions about many aspects of
the reliability and validity estimates of the DAST-20.
Implications for Professional Counselors
After examination of the results of this study, several implications are apparent
for clinical practice, test administration and interpretation for clinicians and researchers,
as well as recommended future research to shed further light on the use of the DAST-20.
Implications of instrument use and recommendations are provided in this section.
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Overall, the DAST-20 seems to yield reliable and valid scores to screen for the
presence of consequences related to an individual’s drug abuse, however, there is need
for more research on the psychometric properties of the DAST-20. Recommendations for
professional counselors are provided below.
As previously mentioned, there was limited data available to compare the DAST20 psychometric properties among various cultural groups (i.e., race, ethnicity, age,
gender). Therefore, counselors should consider multicultural factors that may impact the
results of the instrument until more research can be conducted to examine the use of the
DAST-20 with various groups.
Clinicians should only use the DAST-20 as a screening instrument and not as a
diagnostic tool. Further, Skinner (1982a) indicated that the instrument is not intended to
provide a comprehensive assessment of all aspects of drug abuse. Therefore, counselors
should use this instrument in conjunction with other sources of data collection in relation
to a client’s drug abuse. One area of drug abuse consequences not adequately assessed by
the DAST-20 are psychological consequences. In the literature, many psychological
consequences have been cited related to an individual’s use of drugs, however, the
DAST-20 does not directly assess the presence of these consequences. Other screening
instruments should be used to get a more complete picture of how drug abuse is affecting
an individual’s psychological health and vice versa.
Instruments that rely solely on self-report can be at risk for underreporting of
issues by a client (Erford, 2021). Skinner (1982a) indicated the risk of underreporting on
the DAST. In the current study, no correlations were reported between social desirability
scales and the DAST-20. Underreporting of drug abuse can lead to misidentification for
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further assessment and treatment, as well as inadequate treatment plans. Therefore, it is
recommended that professional counselors use a social desirability instrument in
conjunction with the DAST-20 to provide evidence of whether a client may be
underreporting issues related to drug abuse.
Significant differences are apparent between the aggregated psychometric
estimates found in this study and the estimates reported in the original study of the
DAST-20. The internal consistency estimate from this study was much lower than the
original internal consistency estimate provided by Skinner (1982a). This is important for
professional counselors to consider, however, the aggregated internal consistency still
falls in the range considered appropriate for use as a screening instrument. More
concerning, the analysis of the aggregated data in this study indicated that the original
cutoff score recommended by Skinner (1982a) might be too high, leading to potential
false negatives. This means that a significant number of individuals who should be
identified for further diagnostic evaluation could potentially be missed. Further research
is needed to come to a more definitive conclusion about the most effective cutoff score.
Until this data is available, professionals should consider scores in the range of three to
six. Other instruments and forms of data collection could be used in conjunction with the
DAST-20 when individuals score in this range to help determine whether further
diagnostic assessment is recommended.
Implications for Counseling Research
To further examine evidence of reliability and validity of the DAST-20 scores, more
research is needed. In regard to limitations of the current study, a search for all relevant
published articles from 2015 to 2021 should be acquired and examined for data that can
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be included in the psychometric synthesis. A future study that examines reliability and
validity of the DAST-20 scores in studies published in languages other than English
could provide important multicultural facets of using and interpreting the instrument. It
would also provide a more comprehensive examination of the psychometric properties of
the DAST-20 scores than what was accomplished with the current study. Also, other
psychometric synthesis studies conducted on the other forms of the DAST, including the
original 28-item DAST, the DAST-10, and the DAST-A are recommended. All of the
instruments have been reported to be highly correlated, which would provide further
evidence of validity, as well as implications for the appropriate use and settings for each
instrument.
After completing the data analysis, it was apparent that further research was
needed to fill gaps in the data and examine conflicting data between some of the studies.
As previously mentioned, data for individual groups were not readily available in the
studies included in this psychometric synthesis. Due to the lack of data, multicultural
implications cannot be identified with confidence. Although the DAST-20, overall, yields
valid and reliable scores as a screening instrument for drug abuse, it is important that
cultural factors are studied to make sure that it is sufficient to use among various
populations. The ACA (2014) Code of Ethics specifies the responsibility of clinicians and
researchers to consider possible implications of using specific instruments without
considering cultural factors (i.e., “age, color, culture, disability, ethnic group, gender,
race, language preference, religion, spirituality, sexual orientation, and socioeconomic
status”) (p. 11). It is also imperative that authors publish data for individual groups in
future research articles in order for more psychometric syntheses such as the current
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study to have the data necessary to investigate potential differences and how they affect
outcomes. Further, professional journal editors should require more detailed data be
reported in accepted research articles related to multicultural implications and differences
among groups.
Measurement invariance was not assessed in any of the articles. Measurement
invariance examines how individuals across diverse backgrounds respond to items on an
instrument and how any differences can impact the way the items are interpreted. For
example, do men and women interpret the items in the same way and therefore, do the
results have the same meaning across gender? Not only does more validity and reliability
data need to be collected across various groups, measurement invariance of the DAST-20
items also should be studied.
Conflicting evidence of structural validity was reported among studies. Some of
these studies were underpowered. Future psychometric studies of the DAST-20 should
include larger sample sizes of at least 500 participants. A future confirmatory factor
analysis study using a community sample of at least 500 participants is recommended.
Except for the original study of the DAST-20 completed by Skinner (1982) when
creating the screening instrument, only one other study found provided evidence from a
confirmatory factor analysis. There were only three studies included in this psychometric
synthesis that conducted exploratory factor analyses on the DAST-20, resulting in three
different conclusions. Also, updated procedures for interpretation of EFA have been
established (Tabachnik & Fidell, 2019). Therefore, more EFA studies need to be
conducted using the updated procedures to produce a more accurate picture of factor
loadings.
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One of the issues in comparing findings from various studies was the lack of
consistent criterion measures. The DSM-III, DSM-IV, and the ICD were all used as
criterion measures for diagnostic validity, making it difficult to aggregate data and make
more definitive conclusions about cutoff scores, as well as other psychometric properties.
In regard to the DSM, future research should examine the validity of DAST-20 scores
when using the DSM-V as the criterion measure, as it is the most recent version of the
manual and is widely used for substance abuse evaluation. It must be noted that these
studies might already exist, as the current study only accepted articles up to 2014. This
data should be added to the current analysis for an updated examination of the DAST-20.
Only six articles included in the psychometric synthesis reported data on the diagnostic
validity of the DAST-20 and recommended multiple different cutoff scores to use when
screening for drug abuse. More studies are needed on the diagnostic validity of the
DAST-20 in order to gain greater agreement on cutoff scores among varying groups and
to assess the instrument’s use as part of a diagnostic protocol.
Finally, as mentioned in the recommendation section for professional counselors,
none of the studies included in the current study reported correlation estimates for the
DAST-20 and a social desirability scale. Skinner (1982a) acknowledged that the DAST
does not prevent or detect underreporting of substance abuse. Therefore, studies
examining the use of the DAST-20 and social desirability scales could shed light on how
underreporting affects DAST-20 scores, especially diagnostic validity and how these
instruments should be used together during evaluation.
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Conclusion
This chapter discussed the interpretation of the results of the psychometric
synthesis of the DAST-20 and the significance of the findings. Findings conclude that
counselors should use the instrument with clients with confidence, as the overall
reliability and validity estimates are adequate. However, some of the data was limited and
further research is recommended to continue to examine the DAST-20, such as
multicultural implications. Limitations of the study were discussed and recommendations
for professional counselors and researchers were provided.
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